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Abstract

RESOLUTION OF PROXIMAL OXIDATIVE BASE DAMAGE AND 3′-PHOSPHATE
TERMINI IN NONHOMOLOGOUS END JOINING OF FREE RADICAL-MEDIATED DNA
DOUBLE-STRAND BREAKS

By Sri Lakshmi Chalasani

A dissertation submitted in partial fulfillment of the requirements for the degree of Doctor
of Philosophy at Virginia Commonwealth University

Advisor: Lawrence F. Povirk, Professor, Department of Pharmacology and Toxicology,
Virginia Commonwealth University, Richmond, Virginia.

Clustered damage to the DNA is a signature mark of radiation-induced damage, which
involves damage to the nucleobases and/or DNA backbone. Modification of the bases
and strand breaks with the altered composition are a common occurrence at these
clusters, imposing a difficulty in processing these lesions, requiring multiple repair
pathways or repair factors to handle the lesions. Double-strand breaks created either
directly or indirectly by the repair enzymes are detrimental to the cell survival, as they can
lead to chromosomal translocations. Normal cells employ Non-homologous end-joining
because of its faster kinetics and a limited homology requirements to suppress the

chromosomal translocations. However, the presence of complex DNA ends constitutes
a significant challenge to NHEJ. One such lesion, thymine glycol (Tg), an oxidized
thymine lesion was shown to be a lethal due to its propensity to block replicative DNA
polymerases. Location of Tg at the 3′ overhang proved to be a potential hindrance to
end joining compared to an oxidized purine lesion, 8-oxo-guanine. Positioning Tg at the
3′ end of the blunt double-strand break also inhibited the end joining, but much less when
moved to the third position (Tg3) from the end. Positioning it at the fifth position (Tg5),
however, reduced the end joining, due to increased removal of Tg from a DNA DSB end.
Assaying for the removal of Tg by purified hNTH1 protein, Tg5 was shown to be a better
substrate than Tg3, potentially explaining the increased Tg removal and decreased end
joining in extracts. Moreover, Tg at second (5′ Tg2) and third (5′-Tg3) positions at 5′ end
of the double strand allowed for end joining even when at the second position, unlike its
3′ counterparts, displaying no preference to processing by hNTH1.
Strand breaks caused either by radiation, chemotherapeutic drugs or as
intermediates during processing other lesions, also possess unligatable ends with a 3′phosphate with/without 5′-hydroxyl ends. Polynucleotide kinase phosphatase (PNKP)
enzyme is crucial in restoring the 3′ hydroxyl, and 5′ phosphate ends, thus playing a
pivotal role in the repair of single and double strand breaks. Targeting PNKP is found to
be beneficial in sensitizing the cells to cancer treatment, along with being a synthetic
lethal target in cancers lacking a tumor suppressor gene. Experiments done in the current
study to explore the activities of PNKP in its absence have revealed surprising results.
PNKP knockout derivatives of two cell lines, HCT116, and HeLa, displayed a 3′
phosphatase activity on the overhang and recessed 3′-phosphate ends, in extracts, and

also in-vivo, albeit less than the parental wild-type. Processing of the recessed ends was
found to be lesser than the overhangs, even in the wild-type, with a substantial decrease
in the knockouts of both cell lines. NU7441, a DNA-PK inhibitor significantly blocked the
activity in both wild-type and knockout extracts, while the PNKP inhibitor, ST042164
inhibited the DNA 3′ phosphatase activity in wild-type and not the PNKP knockout. DNA
5′ Kinase activity was also evident in PNKP knockout extracts of both HCT116 and HeLa
cell lines. Overall, these results suggest the presence of less efficient alternatives to
PNKP for both 3′ phosphatase and 5′ kinase activities in the cells. Also, among the core
NHEJ proteins, XRCC4 has been shown to potentiate both activities of PNKP, while XLF
enhanced the kinase activity.

General Introduction

Deoxyribonucleic acid (DNA) is one of the four major molecules that are
essential for all known forms of life. It carries the genetic information encoded in order via
the four nitrogen-containing nucleobases — cytosine (C), guanine (G), adenine (A), or
thymine (T), a sugar - deoxyribose, and a phosphate group (nucleotides). These
nucleotides form two biopolymer antiparallel stands bound together by base pairing rules
(A with T, and C with G), with hydrogen bonds and form a double helix of double-stranded
DNA. This information determines the structure, function, growth and development, and
reproduction of the living beings. These DNA sequences are highly conserved in evolution
and persisted as genetic information despite the constant disturbing influence. These
insults came from the usual cellular environments or physiological events, and natural
physical agents from external sources such as UV radiation, ionizing radiation, cosmic
rays or human-made reactive chemicals, potentially altering the composition and integrity
of the DNA. About 18,000 purines are lost in each cell every day, and there will be a
conversion of about 100-500 cytosine residues into uracil by deamination. Also, DNA
aberrations can also arise from physiological processes such as base mismatches
introduced during DNA replication(Jackson & Bartek, 2009), or from the release of
reactive oxygen and nitrogen species (ROS/RNS) upon oxidative respiration or through
redox-cycling events mediated by heavy metals. Additionally, oncogenic signaling may
1

cause replication stress resulting in genome instability (Sacco, 2009). On the other hand,
the external genotoxic agents, such as ultraviolet light from the sun, IR from cosmic
radiation and chemical agents used in cancer therapy utilizing X-rays or radiation can
induce a diversity of lesions in DNA including changes or losses of bases (abasic sites),
intrastrand or interstrand crosslinks between two complementary DNA strands, SSBs and
DSBs. Many such damages occur in conjunction with one another resulting in "clustered
lesions." These lesions have a propensity to block genome replication and transcription,
and if not repaired or misrepaired, they lead to mutations or wider-scale genome
aberrations that threaten cell or organism viability. To address the vast number of DNA
lesions, a cell encounters each day, a myriad of elegant repair mechanisms have evolved
to ensure faithful propagation of genetic material to daughter cells, and are essential for
life. Hence, these repair pathways are critical and described as guardians of the human
genome (Sishc & Davis, 2017). However, this DNA damage response might be a
hindrance in treating cancer as DNA damage is the prime detrimental target for cancer
chemotherapy or radiotherapy. Several inhibitors of specific proteins / factors involved in
DNA damage response that is responsible for the survival of the cancer cells are under
study, to sensitize the resistant cells to the regular treatments. Moreover, some of the
tumor cells can be addicted to the protein (oncogene) for survival and/or can be defective
in specific DNA damage response. These parameters serve as biomarkers to develop
therapeutic strategies. Nonetheless, before considering a damage response/repair as a
target, the mechanism of repair of a particular lesion should be elucidated appropriately
to ensure that there is no compensatory /redundant pathway that can take over in the
absence of the primary pathway. Radiotherapy is notorious to elicit a variety of repair
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responses by inducing a medley of lesions in clusters and is a signature mark of radiation
damage. In my current study, I will be studying the repair of clustered lesions with either
an oxidized base (Thymine glycol) or modified end (3′-Phosphate) at the double strand
break (DSB) of DNA.
1.1 Radiation-induced DNA damage
There has been extensive evidence from the radiation biology studies that DNA damage
can result in various human pathologies such as cancer, premature aging, and chronic
inflammatory conditions (Ciccia & Elledge, 2010). Radiotherapy is one of the primary
modalities of cancer treatment, used either alone or in combination with surgery and
chemotherapy and is considered as a ‘two-edged sword’ as it can induce genetic
modifications in normal tissue along with the loss of clonogenic survival of tumor cells.
Evidence from various animal models has shown that radiation-induced key gene losses
in non-targeted cells can be of DNA damage response, apoptotic and cell cycle control
genes and others, leading to secondary carcinogenesis. This damage caused by radiation
is via linear energy transfer (LET), depositing energy in the biomolecules of cells it passes,
causing chemical modifications. There can be either a direct deposition of energy or
indirectly via formation of reactive chemical species in the surrounding of DNA (Ward,
1988) (Georgakilas, 2008). Radiolysis of water in the vicinity (10 nm) of the DNA is
primarily attributed to the production of hydroxyl radicals (OH-). The nature of lesions
induced is similar to endogenously (ROS) produced lesions sometimes even in a fewer
number. However, what determines the lethality of radiation is the spatial distribution of
lesions induced along the single radiation track. While the endogenously produced
lesions are more homogenously distributed, ionizing radiation produces two or more
3

heterogeneous lesions within one or two helical turns of DNA (Sutherland, Bennett,
Sutherland, & Laval, 2002). Radiation track structure modeling has revealed that the
energy deposition of low-LET radiation leads to two or more lesions within a radius of 1–
4 nM, similar to the diameter of the DNA double helix and its water layers. These signature
lesions produced in a single track of radiation are considered as clustered damage, also
called multiple damaged sites (MDS). These clustered lesions involve a combination of
an oxidized purine or pyrimidine lesions, abasic sites with/ without single-strand breaks
(non-DSB clustered lesions) and double strand breaks (DSB’S) with 3′-phosphate or 3′phosphoglycolate ends and/or modified sugars or bases (complex DSB’s) (Sage &
Shikazono, 2017). These lesions can occur in the opposite strands within few helical turns
termed as “bistranded clusters." High LET radiation (e,g., α-particles, protons, and
carbon-ions) has an elevated propensity to form clustered DNA lesions of higher
complexity (much denser),

even though the overall number of DSB and non-DSB

clustered lesions does not increase, and sometimes even decreases in comparison with
low-LET radiation (M. Hada, 2006) (Georgakilas, O’Neill, & Stewart, 2013b).

4

Fig. 1.1: Increase in LET increases the density but not the number of lesions:
Schematic representation of increase clustering of lesions due to High Linear energy
transfer (LET), depositing the same energy in a limited length inducing same number
different types of DNA lesions, similar to low LET. Figure adapted with permission from
Nikitaki et al., 2015.
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Fig. 1.2: Schematic representation of oxidatively generated DNA damage induced
by ionizing radiation: Oxidatively generated base damage (noted oxyPu, oxyPy, U),
abasic site clustered lesions at the with no DSB, SSB within one or two helix turns of
DNA, produced by a single radiation track, the complexity of which increases with
increasing LET. Complex DSB are DSB associated with several oxidized bases and
abasic sites. Figure adapted with permission from Evelyne Sage and Naoya Shikazono
2017.

6

1.2 Biological significance and Repair of clustered lesions
As explained above a single radiation track has the propensity to cause two main
categories of lesions appearing in a cluster, DSB and non-DSB lesions, usually referred
to as oxidatively-clustered DNA lesions (OCDLs). The repair of the non-DSB cluster
lesions is attempted by BER proteins, Apurinic/apyrimidinic endonuclease1 (APE1) or
Poly(ADP-ribose) polymerase-1 (PARP1), as evidenced from recent studies using
primary human fibroblasts (Das & Sutherland, 2011) or cell extracts (Kutuzov et al., 2011).
The type of lesion, the inter-lesion distance and the orientation of nearby lesions (e.g., bistranded or tandem lesions) are a rate limit to the repair process, resulting in a reduction
or inhibition of the processing enzymes such as the glycosylases and nucleases at these
cluster sites. This slow processing of the lesions leads to the persistence of these lesions
until they hit a replication fork leading to the formation of chromosome breaks, mutations,
and misrepair (J. V Harper, Anderson, & O’Neill, 2010)(Eccles, Lomax, & O’Neill, 2010).
There will be a formation of inadvertent DSB from these clustered lesions during the repair
or replication (J. V Harper et al., 2010). Human AP-endonuclease-1 (hAPE1) is also
capable of producing a DSB by cleaving the two opposite stranded AP sites. DSB can
also result from the formation of nick in the intact strand, during processing of the
apyrimidinic site on the opposite strand. There is a hierarchy of the repair of the lesions
in case of three or more complex lesions to avoid the formation of DSB (Georgakilas,
O’Neill, & Stewart, 2013a). There is a severe impairment of the excision of a base lesion
such as 8-oxo-guanine, opposing an AP site or strand break until the AP site/strand break
is repaired, though it occurs slowly due to the damaged opposed base (Lomax, Cunniffe,
& O’Neill, 2004). While the radiation-induced simple prompt DSB, although carrying 3′-
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ends phosphate and phosphoglycolate can be efficiently and accurately repaired within
1–2 h by non-homologous end joining (NHEJ), DSB clustered DNA lesions resulting from
either direct action of the radiation or as a result of processing of non-DSB clusters are
repaired by non-homologous (NHEJ) or microhomology-mediated end-joining (MMEJ)
(Behjati, et al., 2016). When the DSB is due to replication fork hitting the clustered SSB
lesion, the repair is by homologous recombination

(Groth et al., 2012)(Arnaudeau,

Lundin, & Helleday, 2001). Among the DNA lesions, DSB’s are considered to be most
lethal as their misrepair can lead to genomic instability. Thus, the biological significance
of clustered DNA damage is not only due to the difficulty encountered by the different
DNA repair proteins that process these closely spaced DNA lesions, but also because
several of these OCDLs can be converted into de novo DSBs during repair. A small
fraction of radiation-induced DSBs, and in particular those induced by high LET radiation,
have a slow rate of repair and to require DNA damage response via the ATM pathway.
Thus, there is a possibility of chromosomal abnormalities arising from the repair of
radiation-induced DNA damage via the less accurate non-homologous (NHEJ) or
microhomology-mediated end-joining (MMEJ) (Behjati et al., 2016). leading to leading to
structural abnormalities and subsequently to genomic instability (GI) and cancer.
1.3 DNA Damage Response:
Sophisticated cellular networks sense, signal, and repair DNA lesions, constantly
monitoring genome integrity. Depending on the type of the lesion, the repair can be by,
but not limited to Nucleotide excision repair, Base excision repair, Homologous repair, or
enjoining, and can function in a partial overlap. The proteins detect and bind to DNA
lesions (sensors), activating the signaling pathways via post-translational modifications
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of downstream proteins. Any genetic defects acquired in these response pathways induce
a plethora of consequences affecting normal development, immunological problems,
aging, and cancers.

In response to DNA damage, three distinct functionalities are

activated: (1) damage detection, (2) control of cell cycle and transcriptional programs of
damage response, and (3) mechanisms for catalyzing the repair of the lesion (Lamarche,
Orazio, & Weitzman, 2010). Cell cycle progression and DNA repair are tightly regulated
via cell cycle checkpoints due to activation of orchestrated cell signaling pathways (J. W.
Harper & Elledge, 2007). Minimal damage in the cell activates repair but not arrest,
however with higher levels of damage there will be induction of arrest, in G1 or S, to
prevent replication fork encounter with lesions (D. Branzei, 2009), and in G2 to prevent
mitotic catastrophe (H. Vakifahmetoglu, M. Olsson, 2008). If the damage can’t be
repaired, cells enter one of several programmed death pathways (necrosis or apoptosis).
In the DNA damage spectrum, DSB’s are considered to be fatal as there is no
complementary strand to be used as a template for repair, which can lead to
translocations and chromosomal rearrangements due to aberrant end joining.

In any

phase, Ku 70/80 heterodimers and MRN sensor complex are the first to detect DSB’s to
activate and recruit apical DDR kinase ataxia telangiectasia mutated (ATM) (Uziel et al.,
2003). In S/G2 phase RPA recruits the ATM and Rad3-related (ATR) kinase via its partner
protein, ATR-interacting partner (ATRIP) at the regions of ssDNA exposed by DSB
processing or ssDNA at stalled replication forks (Rouse & Jackson, 2002). A third
signaling pathway involves ATM, p38MAPK and MK2 kinases, converging on to similar
cell cycle regulation targets such as Chk1/2. DNA PKcs, a central protein in C-NHEJ, also
belonging to the same class Phosphatidylinositol 3-kinase-related kinase (PIKK) as ATM
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and ATR has also been discovered to play a central role in DDR signaling, especially
during replication stress (R.-G. Shao et al., 1999).

Although there was an initial

compartmentalization of ATM and ATR response to frank DSBs and replication stress,
respectively, in initial studies, there is always a functional crosstalk and overlap in the
DDR. Mediator proteins for ATM such as BRCA1, MDC1 (mediator of DNA damage
checkpoint) and 53BP1 (p53-binding protein 1) activate the effector kinases Chk1 and
Chk2, spreading the signal throughout the nucleus stalling the progression of cell cycle
(Blackford & Jackson, 2017).
1.4 Repair of double strand breaks:
Repair of DSB’s is by four possible mechanisms. Classic-NHEJ end ligation independent
of sequence homology, by many factors such as Ku70/80, DNA-PKcs, and DNA ligase
IV. Alternatively, the DSB end can be resected leaving 3′ single-stranded DNA (ssDNA)
overhangs can be repaired by three possible mechanisms: HR, SSA, and alt-EJ.
However, recently a resection dependant NHEJ was discovered which is end initiated by
Plk3/CtIP/Brca1, executed by Mre11 exonuclease, EXD2, and Exo1 execute resection,
and completed by Artemis (Biehs et al., 2017). These repair pathways are not
complementary and function under different circumstances. NHEJ does not require a
template and is functional throughout the cell cycle, faster kinetics of resection
independent repair suppressing chromosomal translocations (Difilippantonio et al., 2000)
with resection-dependant form increasing them.(Barton et al., 2014) HR predominates in
the mid-S and mid-G2 cell cycle phases, when a sister template is available and is
typically error-free (Ketki Karanam , Ran Kafri, Alexander Loewer, 2012). When classical
NHEJ or HR is impeded because of a missing or mutated component, alternative end10

joining pathways operate. These alternative end-joining pathways utilize the factors such
as the MRE11–RAD50–NBS1 (MRN) complex, poly(ADP-ribose) polymerase-1 (PARP1), XRCC1, and DNA Ligase I or III that are involved in SSB repair (SSBR) or HR and
there is reliance on terminal micro-homologies for the joining reactions (McVey & Lee,
2008). SSA mediates end joining between interspersed nucleotide repeats in the genome
and involves reannealing of Replication Protein A (RPA)-covered ssDNA by the RAD52
protein. The intervening sequence between the repeats is deleted in the repair product,
thus resulting in loss of genetic information (Heyer, Ehmsen, Liu, & Heyer TEL, 2010).
1.5 Repair Pathway Selection:
In normal cells, DNA DSB’s are repaired by two major pathways- NHEJ and HR. Many
factors decide the choice of repair. One major factor being the cell cycle, NHEJ being
active in all phases of cell cycle, except M-phase, and HR functioning only in S/G2 phase.
Even in G2-phase, 70% of the two ended DSB’s are repaired by NHEJ, and the remaining
30% by HR (Beucher et al., 2009). Irrespective of the stage of the cell cycle NHEJ factors
Ku 70/80 and 53bp1 are the first responders to protect the free DNA ends from extensive
resection. ATM-mediated phosphorylation of 53BP1 recruits RIF-1 protein which inhibits
accumulation of BRCA 1 (HR factor), possibly by modulating the recognition of the
ubiquitylated chromatin due to compaction of 53BP1 at the DSB (Escribano-Díaz et al.,
2013). BRCA1 promotes 53BP1 dephosphorylation via protein phosphatase 4 (PP4) and
RIF1 release to favor homologous recombination (Isono et al., 2017). Further, Ku should
be displaced from the ends for HR to be initiated by RAD51 loading (Chanut, Britton,
Coates, Jackson, & Calsou, 2016). This process is intricately regulated by neddylation,
proteasome-mediated NHEJ complex degradation, phosphorylation, and MRE1111

dependent nuclease digestion of the DNA ends. The MRN complex plays a pivotal role in
directing a DSB down the appropriate repair pathway, via its DNA end-processing
activities (Huertas, 2010). Mre11 with its endonuclease (HR) and exonuclease functions
(HR, NHEJ), along with other exonucleases, initiates a nick or resection of the DNA
strand, respectively, and processes it downstream. One of these exonucleases, Cterminal binding protein 1 (CtIP) is phosphorylated at Ser327 position in a Plk3 (G1) or
CDK (G2), promoting a complex formation between CtIP, Mre11 and BRCA1 (You &
Bailis, 2010) (Barton et al., 2014). In HR, following the initial processing, other nucleases
and helicases (i.e., DNA2, BLM, WRN) produce further resection of DSB generating
extensive 3′ ssDNA overhangs on each side of the break. The ssDNA thus generated is
an excellent substrate for the HR-specific ssDNA-binding factors RPA and Rad51,
(Huertas, 2010) and a poor one for NHEJ-specific double strand DNA termini binding
factor Ku70/80 (Dynan & Yoo, 1998). Several factors such as nuclear architecture,
chromatin and transcriptional context influence repair-pathway choice. The list of the
regulatory proteins and post-translational modifications which play a role in determining
the destiny of the DSB’s has been increasing recently (Drané et al., 2017) (Li et al.,
2017)(Isobe, Nagao, Nozaki, Kimura, & Obuse, 2017) (Mackay, Howa, Werner, & Ullman,
2017) .
1.6 Homologous recombination:
Homologous recombination is the DNA repair process which utilizes a homologous
sequence, on a homologous chromosome or a sister chromatid for accurate DNA repair.
This is a highly conservative process. As discussed above, the initial sensor and
responder to localize at the DSB is the MRN complex (Uziel et al., 2003) which forms
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nuclear foci. MRN complex incites the further steps in HR mechanism by recruiting a
phosphatidylinositol-3-related kinase, ATM, which phosphorylates histone H2AX at
Ser139 position forming γH2AX. MDC1, a mediator protein facilitates the binding and
phosphorylation between ATM and H2AX. By marking one or more megabases of DNA
surrounding the break, γH2AX serves as a molecular beacon signaling the presence of
damage (Davis & Chen, 2013), and forms a scaffold protein for the accumulation of other
proteins in the repair pathway. Formation of NBS1/MRE11/Rad50, 53BP1, and BRCA1
foci is regulated by MDC1.

The RING-finger ubiquitin ligase, RNF8, interacts with

phosphorylated MDC1 with its FHA domain (Mailand et al., 2007), ubiquitinylates H2AX
and facilitates the accumulation of BRCA1 at the site of damage. BRCA1-C complex,
BRCA1-CtIP, is formed by the direct interaction of BRCA-1 and phosphorylated CtIP, and
is recruited by MRN complex (Williams et al., 2009).
Cyclin-dependent kinase’s

phosphorylation of CtIP on Ser327 is essential for

physical interactions between CtIP and BRCA1, which occurs during G2 phase of cycle.
Upon binding to the MRN complex, CtIP catalyzes Mre11 endonuclease activity to
introduce nicks on the DNA duplexes as far as 300 nt from DSB ends. The nick thus
produced triggers Exo1-dependent 5′ -3′ resection, while the Mre11 exonuclease
mediates 3′ -5′ degradation of the nicked strand toward the break releasing any other
proteins such as Ku (NHEJ factor) bound to the DSB, thus blocking NHEJ. This extensive
DSB end resection generates single strand DNA (ssDNA) overhangs. ssDNA binding
complex RPA (replication protein A) coats these ssDNA overhangs initially, later
substituted by RAD 51, forming a nucleoprotein filament. Other recombinant proteins
such as RAD52/RAD54 stabilize this interaction. This RAD51 nucleofilament, together
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with various other HR factors, mediates strand invasion near a homologous sequence in
sister chromatid or homologous chromosome. Once the strand is copied and filled in by
DNA polymerases and ligated by Ligase I, while DNA helicase and resolvase enzymes
mediate the cleavage and resolution of HR intermediates.
1.7 Nonhomologous End Joining:
NHEJ, as the name suggests, involves direct joining of the DNA ends with minimal
processing of the ends. DSB repair in mammals appears to be primarily by NHEJ and
has been traditionally regarded as the guardian of the genome as it prevents genomic
instability by means of its faster kinetics of repair. Moreover, NHEJ is a flexible and
dynamic process that can respond to variable types of DSBs (Davis, Chen, & Chen,
2014). Physiologically, NHEJ factors in addition to protection from damage of internal
ROS, are also crucial for V(D)J recombination for ensuring maturation of immune cells
and for the telomere maintenance. The three main steps of NHEJ are: (I) DNA end
recognition and assembly and stabilization of the NHEJ complex at the DNA doublestrand break; (II) Bridging of the DNA ends and promotion of end stability; (III) DNA end
processing; and (IV) Ligation of the broken ends and dissolution of the NHEJ complex
(Davis & Chen, 2013). Fifteen or more proteins can be involved in the processes
assembling in a confined space around the DNA ends. XRCC5, XRCC6, and XRCC7
are the genes that encode some of the core NHEJ proteins that form DNA-dependent
protein kinase (DNA-PK). XRCC5 and XRCC6 encode the 80 and 70 kDa subunits of the
Ku70/80 heterodimer (the DNA-binding subunit of DNA-PK), and XRCC7 encodes the
470 kDa DNA-catalytic subunit of protein kinase DNA-PKcs (Critchlow & Jackson, 1998).
In addition to the above factors, a heterodimer XRCC4/LigaseIV ligates the strands
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(Critchlow & Jackson, 1998) and Cerrunnos/XLF activates the ligase activity (Critchlow &
Jackson, 1998). Various end processing factors such as Artemis, TdT, WRN, PNK,
hTDP1, FEN1 are required to clean the ends of the DNA of any complexities that hinder
the direct joining and DNA polymerases λ/μ fills in the gaps created in the process.
Proteins such as PARP-3 and APLF accelerate the NHEJ by retaining the XRCC4/LigaseIV complex at the site of break (Rulten et al., 2011). Since there is involvements of so
many factors in the repair complexes, some of them required to compete for the same
binding site, these factors have conserved protein domains or motifs such as XLF-like
motifs (XLMs), FHA domains, Ku-binding motifs (KBMs) and BRCT domains (Rulten &
Grundy, 2017).
1.8 NHEJ Pathway:
DSB associated with V(D)J recombination, irradiation or chemotherapy damage are
primarily recognized by the MRN complex, which by further signaling via ATM,
phosphorylates and activates H2AX to γH2AX. γH2AX recruits BRCA-1 or 53bp1,

the

deciding factors for the pathway of repair. In G1/M oligomers of 53bp1 flank on either
side of the DSB bound to the histones modified by acetylases and methyl transferases.
The chromatin conformation is thus maintained limiting access to transcription and HR
factors (Chapman, Taylor, & Boulton, 2012), promoting NHEJ. Whenever there is a DSB,
irrespective of the cell cycle Ku is the initial protein (Reid et al., 2015) to translocate to the
site and binds dsDNA ends with extremely high affinity (Lieber, 2010) and encircles the
DNA with its preformed channel (Walker, Corpina, & Goldberg, 2001). This binding occurs
in an ATP dependent manner (Dynan & Yoo, 1998) and prevents the DNA ends from
further damage. Ku functions as a signal molecule for the recruitment of further NHEJ
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proteins. Recently, it has been shown that Ku can process the ends of the DNA by virtue
of its 5′-dRP/AP lyase activity, processing the abasic sites by nicking DNA 3′ of the abasic
site via a Schiff-base covalent intermediate (Fell & Schild-Poulter, 2015). After its binding
to the ends, there will be an inward translocation of Ku and recruitment of DNA-PKcs to
form a Ku-DNA-PKcs synaptic complex (DNA-PK) which tethers the DNA ends together
and offers protection from premature nucleolytic degradation (Smith & Jackson, 1999).
Further, synapsis of the juxtaposed DNA ends stimulates autophosphorylation of DNAPKcs by DNA-PK kinase activity, inducing a conformational change in the DNA-PK
complex, mobilising it internally away from the DNA strand breaks, providing access to
other factors (Calsou et al., 1999). In addition to DNA-PKcs, DNA bound Ku also recruits
XRCC4/Ligase IV complex and XLF independently (Yano & Chen, 2008). The recruitment
of the proteins does not require any protein-protein interactions but the assembly of the
proteins does. XRCC4 requires DNA-PKcs, and XLF requires XRCC4 to be retained at
the repair loci. Once recruited, XLF and XRCC4 form a nucleo-filament around the DNA
ends by interacting in a head-head manner. The architectural channel thus formed with
the synergy of Ku-XLF-XRCC4 interaction, stabilizes DSBs and provides accessibility and
activation of Ligase IV (Hammel et al., 2011). Ligase IV is ATP-dependent and uses ATP
to adenylate itself to transfer AMP to the 5′- phosphate of one end of DSB. AMP gets
removed by the nucleophilic attack by the 3′ hydroxyl group of the second DSB end,
yielding a ligation product. XLF stimulates LIG4-mediated ligation via promoting readenylation of Ligase IV (Davis et al., 2014). One distinctive feature of Ligase IV is its
ability to ligate incompatible DNA ends across gaps. Ligation of mismatched and noncohesive ends is stimulated by XLF. As expected of it, NHEJ is an error-prone pathway
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(Lieber, Ma, Pannicke, & Schwarz, 2004), as there will be often removal of the nucleotides
and fill in without the guidance of a template. Loss of nucleotides during the process
makes the DSB repair inaccurate. Except for the recruitment of the Ku heterodimer, the
order of recruitment of other factors is flexible depending on the complexity of the DNA
damage (Reynolds et al., 2012). The recruitment of the NHEJ machinery to the site of
the DSB occurs via a dynamic assembly (Yano, Morotomi-Yano, Adachi, & Akiyama,
2009), rather than a step-wise sequential manner. Ku heterodimer, XRCC4, Ligase IV
and XLF are sufficient for the repair of simple DSB, whereas complex breaks require
DNA-PKcs and ATM activation of a multitude of repair factors to enhance processing of
the damage. As the IR produces complex DSB's with 3′-phosphate or 3′-phosphoglycolate
groups, 3′ and 5′ overhangs with damaged bases and/or ribose units in the vicinity of the
break ends (Nikjoo, O’Neill, Wilson, & Goodhead, 2001), the DNA ends must be
processed before ligation. Enzymes such as Polynucleotide Kinase 3′-Phosphatase
(PNKP), Artemis, FEN-1, WRN, hTDP1, Polymerases belonging to Pol X family (μ and
λ), aid in the processing of the complex DNA ends. DNA Polymerases serve two important
roles, fill-in synthesis of gaps and nucleotide addition to broken DNA ends. Pol μ primarily
adds nucleotides in a template-independent manner, whereas Pol λ primarily has
template-dependent polymerase activity. While Pol PNKP removes the 3′- phosphate
from the DNA ends, Artemis removes the hairpin bend at the the V(D)J associated DSB,
metnase trims the damaged ends (Mohapatra et al., 2013), nucleases remove several
nucleotides from single-stranded overhangs at the DSB ends termini, aprataxin removes
adenylate groups from the 5′ end (Ahel et al., 2006b) , the phosphodiesterases TDP1 and
TDP2 process DNA topoisomerase adducts (Lee et al., 2012), DNA poly merases
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belonging Pol X family fill in the gap, FEN-1 has an exonuclease function, WRN (Werner
syndrome helicase) and BLM (Bloom syndrome helicase) are the unwinding enzymes
(Lee et al., 2012). This extensive processing of the DNA end can result in deletions and
insertions leading to inaccuracy in repair. Even though cNHEJ is inherently error-prone,
there are greater risks associated with cNHEJ defects as the back-up alt-NHEJ pathway
creates larger deletions, mediating translocations (Corneo et al., 2007) (Deriano & Roth,
2013).
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Fig. 1.3: Schematic overview of NHEJ: i) Illustration of a double-strand break (DSB). ii)
Recognition of the DSB produced by an by the heterodimer protein Ku. iii) Recruitment of
the DNA PKcs by Ku and formation of DNA-PK complex by the activation of its kinase
activity. iv) Autophosphorylation of DNA-PKcs shifts the complex inwards exposing the
DNA ends for the processing enzymes. XRCC4-Ligase IV complex in combination with
XLF forms a filament around the broken ends, and vi) once the ends are processed by
specific accessory factors, DNA Ligase IV ligates the ends, vii) followed by disassembly
of the complex after restoring the DNA integrity. Figure adapted with permission from
Grundy et al., 2014.
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1.9 NHEJ – Guardian or Disruptor of the genome?
There is contrasting evidence giving rise to the debate if NHEJ is indeed a protector from
genomic instability. There are numerous studies undermining the role of core NHEJ
factors in promoting healthy neurological and immunological development of the
organism, protection from premature aging and the development of carcinogenesis as
evidenced by increased tumor rates in mouse-models lacking core NHEJ factors(Buck et
al., 2006)(Yan et al., 2006) (Espejel et al., 2004)(Gao et al., 2000). Surprisingly, studies
in human cells, in which site-specific DSBs are introduced using nucleases at
endogenous loci, translocation reporter assays, or DSBs induced by radiation, found that
NHEJ is responsible for the generation of translocations (Rothkamm, Kühne, Jeggo, &
Löbrich, 2001) (Weinstock, Richardson, Elliott, & Jasin, 2006)(Lieber, Gu, Lu, Shimazaki,
& Tsai, 2010). Furthermore, NHEJ is found to be the culprit behind the translocations in
human lymphoid cells and renal cell carcinoma (RCC), with the characteristic small
deletions near the DSB sites, and DNA polymerase μ or Pol λ mediated templateindependent nucleotide insertion (Lieber et al., 2010) (Ali et al., 2013). Chromosomal
translocations can be a consequence of inaccurate end joining of two independent DSBs
on different chromosomes by NHEJ. The probability of this will increase during an
attempted repair of highly complex lesions, or repair of one ended DSBs due to a failure
of HR or pathways such as Fanconi anemia pathway which directs this one ended DSBS
towards HR (Romick-Rosendale et al., 2016). Interestingly, DNA-PKcs-dependent NHEJ
is found to play a role in Chromothripsis, a result of randomly rejoined multiple DSBs of a
chromosome (Ali et al., 2013). Probing into this controversial data researchers have also
found out the role of differential regulation and single nucleotide polymorphisms (SNPs)
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in the core NHEJ genes that correlate with cancer incidence, tumor aggressiveness, and
responsiveness to conventional radiation and chemotherapy. Some tumors have shown
either a decrease of Ku70 levels or DNA-PKcs levels (colon, endometrial, breast and
lung) (Beggs et al., 2012) (Lomnytska et al., 2012) (Lomnytska et al., 2012) (Auckley et
al., 2001), or increase of Ku70 levels or DNA-PKcs levels (myeloid, gastric and colorectal)
(Gaymes, Mufti, & Rassool, 2002) (H. Hu, Zhang, Zou, Yang, & Liang, 2010) (Auckley et
al., 2001), which drive carcinogenesis. Similarly, high Ligase IV expression (prostate
cancer) (GRUPP et al., 2015) or reduced Ligase IV expression, (colorectal cancer)
(Kuhmann et al., 2014) causes tumorigenesis. Also, XLF overexpression in HPV(+)
HNSCCs and down-regulation in HNSCC cells expressing high levels of mutant p53,
promote chromosomal instability and cancer (Feng et al., 2016). Further, genetic single
nucleotide polymorphisms (SNPs) in the core NHEJ factors are found to be associated
with either carcinogenesis (Feng et al., 2016) (Schildkraut et al., 2010) (Wang et al., 2008)
(Hsu et al., 2009), or reduced risk of cancer (Adel Fahmideh et al., 2016) (Andrew et al.,
2015) (Roddam et al., 2002). Differential expression of the NHEJ core factors also
influences the therapeutic responsiveness. While the reduced levels of expression
increase the sensitivity to therapy (Hu et al., 2013) (Tarish et al., 2015) (Jin et al., 2016),
increased levels promote resistance (Jin et al., 2016) (C.-J. Shao, Fu, Shi, Mu, & Chen,
2008) (Shintani et al., 2003). Though traditionally NHEJ is error-prone in the repair of noncompatible DSBs, it is likely to be much more precise than previously believed due to the
flexibility of the NHEJ factors. Nonetheless, cells that are deficient in HR and FA pathways
direct the one-ended DSBs towards NHEJ resulting in chromosomal aberrations,
promoting carcinogenesis. This is because the cell would rather tolerate a chromosomal
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aberration than having an unrepaired DSB which can result in the cell demise (Douglas,
Moorhead, Ye, & Lees-Miller, 2001). Therefore, FA and HR-deficient cells, as a
compensation often overexpress NHEJ factors and become addicted to NHEJ to deal
with a large number of DSBs generated during rapid cell proliferation. Considering the
above scenarios, one can conclude that normal cells use NHEJ to stabilize the genome,
but precancerous and cancer cells utilize NHEJ to drive genomic instability and
carcinogenesis.
All the above observations have led to manipulating, either genetically or
pharmacologically the NHEJ factors to sensitize and improve the responsiveness of
individual cancers to therapy (Jun et al., 2016) (Riabinska et al., 2013) (Winkler, Hofmann,
& Chen, 2014). However, only pharmacological intervention is clinically applicable
currently. Molecular compounds that inhibit either protein-protein, protein-DNA
interactions (Douglas et al., 2001), or activity of the factors with a kinase and/or
phosphatase activity are being explored (Leahy et al., 2004) (Douglas et al., 2001). One
potential problem to translate the in-vitro inhibitor studies to in-vivo is the reduced drug
uptake. Strategically, these inhibitors can be utilized for inducing synthetic lethality. This
approach is recently applied by using DNA-PKcs inhibitors in the treatment of various
cancers including ATM-defective tumors, HR-deficient tumors, and MSH3 deficient
tumors (Lan et al., 2016) (Yanai et al., 2017) (Douglas et al., 2001). DNA-PKcs inhibitor,
CC-115 (Tsuji et al., 2017) is undergoing Phase I clinical trial to be used as an adjunct to
radiation therapy or chemo-radiation therapy.
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1.10 Base Excision Repair
DNA base damage frequently occurs in the cells, at least 10,000 times every day,
spontaneously or by oxidative stress induced by ROS generated by endogenous and
exogenous sources. Oxidation, alkylation, or deamination are the common ways
modifying these bases. Some examples of the modified bases are 7,8-dihydro-8oxoguanine (8-oxoG), 5-methylcytosine (5-meC), (6-meG), N7-methylguanine (7-meG),
or N3-methyladenine (3-meA). While some of these lesions are premutagenic, some of
them are cytotoxic due to their propensity to block replicative polymerases (Lindahl &
Wood, 1999). Various repair pathways take care of these lesions depending on the nature
and complexity of the lesions. One such highly evolved pathway is the Base Excision
repair (BER) pathway mends single oxidized base lesions. There are three functional
processes involved in the repair, 1. Lesion Recognition/Strand Scission, 2. Gap Tailoring,
and 3. DNA Synthesis/Ligation. Each step involves specific protein(s) in a coordinated
fashion such as DNA glycosylases (mono or bi-functional), AP-endonuclease, DNA
polymerases, and ligases. There is about 11 DNA glycosylase discovered and classified
into four structurally distinct superfamilies, the uracil DNA glycosylases (UDGs), the helixhairpin-helix (HhH) glycosylases, the 3-methyl-purine glycosylase (MPG), and the
endonuclease VIII-like (NEIL) glycosylases. These DNA glycosylases scan the DNA via
4Fe4S, employing a damage pre-selection strategy to minimize the effort (Banerjee,
Yang, Karplus, & Verdine, 2005). Mono-functional glycosylates such as UDG, excise the
N-glycosidic bond by hydrolysis (Mol et al., 1995) releasing damaged base creating an
apurinic/apyrimidinic sites (AP-site). AP endonuclease (APE1), cleaves the AP-sites on
the 5′ side of the lesion leaving a 3′-hydroxyl and 5′ deoxyribose phosphate termini (5′-
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Rp). The 5′-dRp termini are taken care of Pol β in case of short patch BER. Bi-functional
glycosylases, on the other hand, have an AP-lyase activity which cleaves the AP-lesion
on the 3′side producing a 3′- unsaturated aldehydic end (β-elimination) with a 5′phosphate
end (NTH1) or a 3′-phosphate and a 5′phosphate end (β and δ elimination) (NEIL). The
3′- the unsaturated aldehydic end is further cleaved by APE1, and the polynucleotide
kinase phosphatase (PNKP) converts the 3′-phosphate end to 3′-hydroxyl end. After
processing the removal of the damaged base, the glycosylases are tightly bound at the
AP-site and requisite APE1 for their release and turnover (Almeida & Sobol, 2007). The
nick and the gap in the DNA strand are further recognized by the XRCC1, which along
with Ligase III and Pol β fills in the gap and ligates the strand as a part of short patch
BER. Under the conditions when a 5′ lesion is refractory to pol β lyase activity, long patch
base excision pathway kicks in (Gary, Kim, Cornelius, Park, & Matsumoto, 1999). During
long patch repair the polymerases δ, ɛ or β function in concert with other proteins such
as proliferating cell nuclear antigen (PCNA), structure-specific flap endonuclease (Fen1),
poly(ADP-ribose)polymerase 1 (PARP1) and LigI, to synthesize DNA to fill in the gap up
to a length of 13 bases. This newly synthesized DNA displaces the 5′ end blocking strand
creating a flap which will be cleaved by FEN1.
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Fig. 1.4: Oxidative DNA base damage repair through BER-pathway: Initiation of BER
is by removal of the modified base by either a monofunctional (M) or bifunctional (B) DNA
glycosylase (DG), which leaves an AP site. If monofunctional enzyme cleaves the
glycosidic bond APE1 incises the DNA backbone 5′ to the AP site. The single strand
breaks (SSBs) left by the both DG and MG contain either a 3′ or 5′ obstructive termini.
These end breaks are recognized by PARP1and processed by pol-β, APE1 or PNKP
depending on the specific nature of the terminus. When 3′-OH and 5′-P termini result from
end processing, the BER and SSBR diverge into two sub-pathways, short-patch (SN) and
long-patch (LP) BER/SSBR. In SN-BER/SSBR, the single nucleotide gap is filled in by
pol β aided by the XRCC1 scaffold in the presence of PNKP and ligated by Ligase III. In
LP-BER/SSBR, Pol δ/ε with the aid of PCNA, 2 to 13 nucleotide gap is filled in, and the
resulting 5′ flap is removed by FEN-1. As with the SN-BER final ligation step is
accomplished by Ligase I. Figure adapted with permission from A.K. Mantha et al. 2014.
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Chapter1

RESOLUTION OF PROXIMAL THYMINE GLYCOL AT DSB TERMINI BY BASE
EXCISION REPAIR AND ITS INTERFERENCE IN NONHOMOLOGOUS END JOINING
OF FREE RADICAL-MEDIATED DNA DOUBLE-STRAND BREAKS

II. Introduction

2.1 Thymine glycol lesions:
As discussed before, the formation of oxidative lesions is not uncommon even under
normal physiological conditions. During irradiation, the energy deposition is proportional
to mass, and hence the purines (adenine and guanine) and pyrimidines (cytosine and
thymine) are about equally likely to sustain damage through the direct mechanism (JF,
1988). Thymine glycol is the most easily damaged base formed due to oxidation of
thymine or deamination and oxidation 5-methylcytosine by ionizing radiation or cancer
therapy (Adelman, Saul, & Ames, 1988). Radiation generates oxidants that can react with
thymine leading to the formation of thymine glycol, thymine peroxide, thymine hydro
peroxide, and other oxidized forms of the base. Further reaction to these products yields
urea. Approximately 10%-20% of the radiation or radiotherapy-induced damage results
in thymine base oxidation and DNA fragmentation(Kung & Bolton, 1997). Thymine glycol
has four diastereomers of, i.e. (5R, 6S), (5R, 6R), (5S, 6R) and (5S, 6S), but in solution
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exists as either the 5R cis-trans pair [(5R, 6S) and (5R, 6R)] or the 5S cis-trans pair [(5S,
6R) and (5S, 6S)], due to epimerization at the C6 position (Lustig, Cadet, Boorstein, &
Teebor, 1992). Oxidation of free thymidine or thymidine in the oligonucleotides
preferentially yields (5R, 6S)-thymine glycol (Kao, Goljer, Phan, & Bolton, 1993a)
(Vaishnav, Holwitt, Swenberg, Lee, & Kan, 1991). According to calculations, cis-(5R,6S)
diastereomer is the most stable one amongst all the isomers of thymine glycol. Depending
on the original base that is oxidized, Tg is found to pair with either A (Thymine) or G
9methyl-cytosine). Thymine glycol has the propensity to cause both structural and
functional perturbations of the DNA. The free radical addition to the C (5)C (6) double
bond of thymine produces a nonplanar ring-saturated lesion making it extra helical as
shown by NMR studies and by its accessibility in the solution (Kao, Goljer, Phan, & Bolton,
1993b) (Kao et al., 1993b). Two possible consequences of Tg lesions are either it blocks
the DNA polymerases or gets bypassed by translesional synthesis and become
mutagenic.
Unlike 8 oxo-guanine, Tg is a weak mutagen (Ashis K Basu et al.,1989), but a
potent blocker of both DNA repair and replicative polymerases, proving lethal to the cells
in the absence of translesional synthesis or recombination (Wallace, 2002). Studies using
a template containing thymine glycol for primer extension with several DNA polymerases
have shown that the extension occurs up to the site of Tg with adenine insertion and not
beyond, especially if the 5′-neighbor is a purine as the protruding C5 methyl group of Tg
pushes the purine extra-helical. This displaced base will be stabilized by the hydrogen
bonds between NH2 and N3 of G on the minor groove’s side and C4 and C5 hydroxyls of
Tg on the major groove’s side. This limits the next incoming dNTP incorporation into the
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primer strand, providing a rationale for the strong bock to replication (Ide, Kow, & Wallace,
1985) (R C Hayes & LeClerc, 1986). This effect is less evident if the 5′-neighbor is a
pyrimidine. Meanwhile, there are several contexts in which thymine glycol is bypassed by
certain DNA polymerases in vitro (R C Hayes & LeClerc, 1986) and in vivo (A K Basu,
Loechler, Leadon, & Essigmann, 1989).
Repair of a simple thymine glycol lesion is major via single nucleotide patch
base excision repair pathway (A K Basu et al., 1989) and in part by Nucleotide excision
pathway (NER) and by recombination. Enzymes Endonucleases III and VIII in E.coli and
their human homologs Nth1 and NEIL (1,2,3) respectively, stereoselectively repair
thymine glycol lesions (Katafuchi et al., 2004). 5R Tg is preferentially removed from
chromosomal DNA in irradiated human cells, whereas 5S Tg is preferentially excised in
irradiated E. coli cells (Shibata, 2017). The repair is sequence and counter-base
dependent, Tg.G being repaired more efficiently than Tg.A by NEIL 1 (Marenstein et al.,
2003). The counter base and the accompanying sequences have the propensity to either
block the replication or promote misinsertion during translesional synthesis (Dolinnaya,
Kubareva, Romanova, Trikin, & Oretskaya, 2013a).
In tandem lesions of 5′- abasic site and Tg, there is a severe replicative block and if at
all bypassed the lesion becomes highly mutagenic, especially if accompanied by 3′-G due
to a misalignment-realignment mechanism (Huang, Imoto, & Greenberg, 2009). If the
tandem lesions have 5′-(8-oxoG)Tg and 5′-Tg (8-oxoG), there is enhanced mutagenicity
of these lesions compared to 8-oxoG alone. In contrast, there is enhanced repair of 8-oxo
G by hOGG1 in case of 3′-Tg but unaffected by 5′-Tg. In case of bistranded lesions, if Tg
is opposite the abasic site, BER or replication induce a double strand break, while the 828

oxo G protects at the expense of increasing mutations. At the double strand break, if
present in an overhang, 8-oxoG is more tolerant than thymine glycol (R.-Z. Zhou et al.,
2008a). In the current study, we are evaluating the role of Tg in end-joining when present
at a blunt double-strand break.
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Fig. 2.1: Formation of thymine glycol: Reactive oxygen species (ROS), such as
peroxide and hydroxyl radicals, are generated as byproducts during normal oxidative
metabolism, and ionizing radiation modifies DNA bases. A typical product of thymine
oxidation is thymine glycol. Figure adapted from Aller et al. 2007.
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2.2 Human EndoIII like protein (hNTH1):
hNTH1 enzyme is a bifunctional DNA N-glycosylase/apurinic/apyrimidinic (AP) lyase and
a human homolog of E. coli endonuclease III. hNTH1 removes ring-saturated pyrimidines,
be they hydrated, reduced, or oxidized, from the DNA backbone as the initial step of base
excision repair (BER). It is a product of the OCTS3 gene, 312 amino acids in length with
a calculated molecular mass of 34,300 Da. Like its other homologs, the hNTH1 sequence
has highly conserved four cysteine residues donning a binding motif for the [4Fe-4S]
cluster, and a helix–hairpin–helix motif that has been shown in the case of E. coli
endonuclease III to contribute to DNA binding of the enzyme (Thayer, Ahern, Xing,
Cunningham, & Tainer, 1995). The Lys-220 in the helix–hairpin–helix motif interacts with
the flipped out damaged base, thymine glycol in the current scenario but is not a specific
substrate. The ε-amino group of this lysine catalyzes the formation of N-acylimine (Schiff’s
base) enzyme-substrate intermediate, which is essential for the enzymatic catalysis of
the β-elimination, a characteristic of an APlyase. The hydrolysis of the Schiff base
intermediate by acid-base catalysis at the active site produces an AP site with the release
the damaged base and abstraction of the deoxyribose pro-S-2′-hydrogendeoxyribose
sugar at the site results in a strand break with 3′ α,β unsaturated aldehyde and a
5′phosphate (Marenstein et al., 2003). It was noted that AP-lyase function is 7 times
slower than the DNA glycosylase activity (Ikeda et al., 1998). The 3′-dRp generated at
the AP-site is later cleaved by APE1 to produce a 3′-hydroxyl end which can further be
filled in by Polβ, and ligated by Ligase IIIα.
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Fig. 2.2: Schematic representation of removal of Thymine glycol by NTH1 protein:
The flipped out Tg lesion on the DNA strand is recognized and removed by NTH1,
followed by β-elimination of the AP-site producing a 3′-deoxyribose phosphate (3′-dRp)
as a unsaturated aldehyde. 3′dRp is further cleaved either by APE1 to leave a 3′ hydroxyl
end. The resulting gap is filled in by Polβ and LigaseIIIα ligates the strand.
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Hypothesis

Thymine glycol (Tg) is better removed from the substrate when placed away from the
double strand DNA break by Base Excision Repair with possible interference with
Nonhomologous end joining.
Background:
Previous experiments done with Tg positioned at various positions, first (Tg1), second
(Tg2), third (Tg3) and fifth position (Tg5) at the blunt DSB have shown the end joining in
the order of Tg3>Tg5>Tg2>Tg1, in Bus whole cell extracts. This observation was in
contrast to our expectation that Tg5 will be joined efficiently due to Tg placement away
from the break. Also, we saw an extra product, 3 or 5 bases lesser, being formed during
repair of Tg3 and Tg5, respectively, corresponding to a product that would result from the
removal of Tg from the third or fifth position of the corresponding substrate. This product
was more prominent for Tg5 than for Tg3. Since Tg is a substrate for hNTH1 of BER, we
wanted to verify if Tg5 is a better substrate for hNTH1, which might have resulted in the
reduction of the end a joining due to the interference of BER with NHEJ. Similarly, we
wanted to test the preference of hNTH1/BER for 5′-Tg’s.
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2.3: Specific aims

1. To compare the processing of the substrates with Tg placed at third position from
the 3′-end of the DSB (Tg3) to that of Tg placed at fifth position (Tg5) by the
recombinant hNTH1 protein
2. To compare the processing of Tg placed at second position from the 5′-end (5′Tg 2) o that of Tg at third position at the 5′-end (5′-Tg 3) in Bus cell extracts with
XLF and by the recombinant hNTH1
3. To verify the processing of 3′ and 5′-Tg substrates in HCT116 cell extracts
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III. Materials And Methods

3.1 Substrate
The

oligonucleotides,

5′-ATGCGGATCGCGTTGTCTg-3′

(Tg1),

5′-

ATGCGGATCGCGTTGCTgC-3′ (Tg2), 5′-ATGCGGATCGCGTTG-Tg-CT-3′ (Tg3) and
5′-ATGCGGATCGCGT-Tg-GT CT-3′ (Tg5) were ordered from Midland Certified
Reagents (Midland, TX). They were re-suspended in TE (10 mM Tris–HCl, pH 8, and 0.1
mM EDTA). 1mCi of [γ-32P] ATP was used to label 50 pmoles of the oligonucleotide, using
Polynucleotide kinase (PNK) and incubated for 1 hr at 37 °C. Each oligomer was then
annealed to an equal quantity of a complementary 5′- phosphate containing, 3′GTATACGCCTAGCGCAACGAGp-5′ or 3′-GTATACGCCTAGCGCAACAGAp-5′, via
heating to 80 °C followed by slow cooling to 10 °C. The duplexes generated by this
annealing process included, on one end a 3-base 3′overhang that was complementary to
the 3′ overhang created by BstAPI digestion of pUC19.
3.2 Ligation of oligomeric duplexes to the KasI/BstAPI cleaved pUC19:
17 μg of the plasmid pUC19 DNA is digested with 50 units of KasI (NEB) in 0.3 ml of NEB
CutSmart buffer for 3 hr at 37 °C and then digested with 50 units of BstAPI in the same
buffer for 3 hr at 60 °C. The 2.6-kb KasI-BstAPI fragment was purified on a 0.8% agarose
gel, electro eluted and concentrated with an ultracel 100k centrifugal filter.
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10 pmole of the annealed oligomers were combined with (~1.7 pmole) of KasI/BstAPI
fragment and treated with 12,000 units (4 μl) T7 DNA ligase in to ligate them at the BstAPI
end in 130 μl of ligation buffer for 2 hr at 25 °C. Proteolysis and ethanol precipitated
extraction of the ligation products is done. These products are then digested with SmaI
(500 units) for 2 hours at 25 °C in 50 μl CutSmart Buffer. This removes 177 bp from the
KasI-end and leaves a blunt end. The resulting 2.6-kb substrate has one Tg-modified end.
This substrate is electro eluted and concentrated as above. T7 ligase was used for ligase
instead of T4 ligase due to its preferential ligation of only cohesive and not the blunt ends
(Doherty at al. 1996; Subramanya et al.1996). Some self-ligation was detected in case of
the unmodified control oligomers, and therefore for these oligomers, the T7 Ligase was
reduced to only 2400 units. In the case of Tg5 plasmid there some ligation seen between
head-head blunt ends, and cutting the plasmid with Sma I enzyme would have eliminated
any head-tail ligation. The ligation products were purified by agarose gel electrophoresis
and electroelution (Bennett et al. 1996).
3.3 Electroelution of the modified substrate:
The nucleotide is electroeluted using an 11-inch segment of pretreated dialysis tubing
(6,000-8,000 molecular weight) filled with the buffer composed of 20 mM Tris, pH8 and 1
mM EDTA (the elution buffer). The gel slice containing the desired DNA band was placed
in the dialysis tubing, and the other end of it was knotted after removal of air bubbles. The
dialysis tube was placed in a gel box filled with the same buffer, and the DNA was eluted
overnight at 50 V. Then the dialysis bag was cut, and the buffer containing DNA substrate
was collected into 15 ml centrifuge tubes. 0.45 μm filters were used to remove any debris,
and the DNA was concentrated by micro- concentration to about 500 μl using centricon36

100 (Amicon). The concentrate was collected into 1.5 ml Eppendorf tubes and
precipitated with 1/9 volumes of NaOAc and 2.5 volumes of 100% EtOH, washed with
70% EtOH and dissolved in 50 μl TE.
3.4 Bus cell and HCT116 cell extract preparation:
Bus cells were grown into confluence on thirty 15 cm dishes each with 20 ml alphaMEM medium with 10% FBS. HCT116 cells were grown to a confluency of 70% - 90%
and then serum starved with 0.5% FBS for 4 days. On the day of the experiment, the
dishes were washed with 20 ml PBS at room temperature. 3 ml of 0.25% trypsin-EDTA
was added to each dish, making sure it covers all the cells. They were incubated for 5
min until the cells are detached and then 3 ml medium and serum was added. These
samples were collected and pelleted in 50 ml tubes at 1500 rpm for 5 min in ultracentrifuge
using SW55 rotor at room temperature. The cells were resuspended in 50 ml medium
and serum and pelleted again. The pellet was again resuspended in 25 ml medium and
serum and pelleted again. The pellet was resuspended in 30 ml ice-cold PBS and pelleted
at 4 °C and packed cell volume (PCV) is recorded. The last process was repeated. The
pelleted cells were resuspended in 5 X PCV cold hypotonic buffer containing 10 mM TrisHCl pH 8, 1 mM EDTA, 5 mM DTT and proteinase inhibitors pepstatin 1 μg/ml,
chymostatin 1 μg/ml, aprotinin 2 μg/ml, leupeptin 1 μg/ml, PMSF 1 mM. The cells were
quickly pelleted. This pellet was again resuspended in 2 X PCV hypotonic buffer and
inhibitors and let set on ice 20 min. 1.5 ml of this solution was put in a small dounce
homogenizer each time and stroked 20 times. After it was let set for 20 min, it was
transferred to cold 5 ml centrifuge and ¼ volume of the hypertonic solution ( 83.5 mM Tris
Ph 7.5, 1.65 M KCl, 3.3 mM EDTA, 1 mM DTT) and inverted several times to mix well.
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This was centrifuged at 43K for 3 hr in SW55 at 2 °C. From the top the middle layer which
has cytosol was collected using a 22G needle, avoiding cloudy layer on the top. The
cytoplasm thus collected was dialyzed for 3 hr in storage buffer (20 mM Tris pH 8, 0.1 M
KOAC, 1 mM DTT, 0.5 mM EDTA, 20% glycerol) with inhibitors at 4 °C. The resulting
solution was freezed in small aliquots (10 μl - 80 μl) at -80 °C.
3.5 End joining assays using cell extracts:
Bustel whole cell extracts which are deficient in XLF or HCT116 whole cell extracts were
used for the reactions in a buffer containing 50 mM triethanolammonium acetate (pH 8),
1 mM ATP, 1 mM DTT, 50 μg/ml BSA, 1.3 mM Mg(OAc)2 and dNTPs at 100 μM each.
The total reaction volume was 16 μl, with 10 μl of extract, resulting in a final protein
concentration of 8 mg/ml. 200 nM of human recombinant protein XLF was substituted for
some reactions. 100 ng of the substrate was added and the reaction mixed by pipetting
and incubated at 37 °C for 6 hr. Samples were deproteinized by adding an End Joining
Lysis buffer containing 1 mg/ml of Proteinase K for 3 hr at 56 °C. The DNA was then
extracted after proteolysis and precipitation with glycoblue and ethanol after one hour.
After the precipitation, all samples were dissolved in 43 μl of TE and digested with 20
units of NdeI and PstI and 5 μl of 10X CutSmart buffer (New England Biolabs) at 37 °C
for 3 hr. Gel electrophoresis of the samples was done in 20% polyacrylamide sequencing
gels. Then the gels were exposed to phosphor imaging screen for 1 to 2 days at -20 °C.
Data were analyzed using a Typhoon 9100 imager (GE Healthcare Bio-Sciences,
Pittsburgh) and Image Quant 3.1 or 5.1 software (GE Healthcare Bio-Sciences,
Pittsburgh). The percentage of end joining was determined by measuring the percentage
radioactivity of the joined fragments as a function of total radioactivity in the same lane.
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3.6 Polyacrylamide gel electrophoresis:
For electrophoretic separation of the DNA strands, Polyacrylamide gels (20x30x0.08 cm)
containing 40% acrylamide: bisacrylamide in a ratio of 20:1, 8 ml of 10XTBE and urea in
a final concentration of 8.3 M were used in total volume of 80 ml. The mixture was cooled
to room temperature, and 0.06 g ammonium persulfate and 45 μl of TEMED (N’, N,’ N’,
N’-tetramethylethylene diamine) were added. The gel was allowed to polymerize for 1
hour. 15 μl of samples are then loaded into the wells of the gel and electrophoresed at a
constant power of 42 W until the marker reached the bottom of the gel.
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Fig. 3.1: Preparation of the substrate: The oligonucleotide with Tg was radiolabeled
with P32 at 5′ end is annealed with a complementary strand. This was ligated to the BstAPI
cut end of the pUC19 using T7 DNA Ligase. The substrate thus prepared had a head with
BstAPI and NdeI restriction sites and a tail with SmaI and PstI restriction sites. This
substrate was used in both cell extract ligation assay and assay with recombinant
proteins.
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Preliminary Data

A.

B.

1 2 3 4 5 6
3.2 Comparison of the repair between Tg3 and Tg5: A) Autoradiograph showing the
repair (joining and BER) fragments of Tg0, Tg3, and Tg5 in Bus cell extracts
supplemented with XLF. B) The graph is representing the percentage of both joining and
BER fragment for Tg3 (16-bp) and Tg5 (14-bp). (n = 3)
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IV. Results

Double-strand breaks induced by DNA damaging agents have the
propensity to turn lethal for cell survival if unrepaired or misrepaired. The complexity of
composition at these breaks renders them more resistant to repair by NHEJ, which tends
to ligate simple double-strand breaks spontaneously. One such structural hindrance is
posed commonly by the presence of oxidized bases at or near the end of the DNA
strands. Oxidized bases are a common result due to energy transfers and radiolysis
during irradiation or internal metabolic processes. Since the production of these lesions
in isolation is robust even during normal metabolism, there is a highly evolved Base
Excision Repair (BER) pathway that executes the repair of oxidized bases, with a minor
contribution from other repair pathways such as NER (David, O’Shea, & Kundu, 2007).
Nonetheless, when oxidized lesions are complexed with DNA double-strand breaks, there
will be an interplay between NHEJ and BER. To evaluate the interference of these lesions
with NHEJ, DSB’s substrate with partially complementary (–ATG and –ACA) 3′ overhangs
with oxidized bases, either 8-oxo guanine (8-oxoG) as a terminal base or Thymine glycol
(Tg) as a penultimate base were analyzed for end joining. These studies revealed Tg as
a substantial hindrance to gap-filling and hence the end joining (R.-Z. Zhou et al., 2008b).
Other studies have also shown Tg as a lethal modification in contrast to 8-oxoG which
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was mutagenic (Bellon, Shikazono, Cunniffe, Lomax, & O’Neill, 2009) (Pearson,
Shikazono, Thacker, & O’Neill, 2004).
To further evaluate the influence of Tg on NHEJ, blunt-ended DSB substrates
were designed. These substrates were internally radiolabeled, and have Tg at different
positions near one of the ends as shown in the Fig. 4.1. These blunt DSB’s were tested
in cell extracts and recombinant protein assays. An increase in the end-joining was
observed with the increase Tg position from the double strand break (Tg3>Tg2>Tg1)
(Mohammed Almohaini et al., 2016). Surprisingly, a reduced end-joining substrate with
Tg placed at the fifth position was observed compared to Tg at the third position (10% vs.
14%) (Fig. 3.2 lane 1 vs. lane 3). Also, there was the appearance of an extra band
corresponding to the length of either 3-nucleotides (16-bp, lane 3) for Tg3 or 5 nucleotides
(14-bp, lane 1) for Tg5, lesser than the usual unjoined (19-bp) band, suggesting removal
of the Tg from the substrates. Further, the intensity of this band differed vastly for these
substrates, Tg3 - 7.6% vs. Tg5 - 48.5% (lane 3 vs. lane 1).

Formation of this smaller

fragment was almost instantaneous for Tg5 substrate.
This disparity in the end joining and the production of the smaller fragments can be
explained by the attempted repair of the substrates by BER interfering with the end-joining
process (Fig. 4.3). The recombinant protein assay with NHEJ core proteins confirmed this
by showing an increased end joining in Tg5 substrates in comparison with Tg3 (7.2% vs.
3.3%). When the Klenow Exo- polymerase enzyme was used on the substrate incubated
for either 5 min, before it was digested, there was the conversion of almost all the 14-bp
fragment to 19-bp or 20-bp (due to the addition of one extra-base by the enzyme) at 5
min time point. However, substrate incubated for 6 hr showed the addition of bases
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between 14-bp to 20-bp suggesting a nucleolytic degradation of the 5′ overhang of the
complementary strand with time leading to the failure of the end joining of Tg5 substrate.
To verify if the interference with NHEJ by BER is dependant on the position of Tg in the
substrate, one of the major DNA glycosylases, hNTH1, which targets oxidized pyrimidine
lesions, was tested on the Tg DSB substrates.
4.1 Recombinant protein hNTH1 activity on 3′ Tg substrates:
There are various enzymes in place to remove and repair the damaged base in base
excision repair. DNA glycosylases, monofunctional and bifunctional excise the damaged
base in a lesion and function specific manner. Oxidized pyrimidines are resolved by two
specific enzymes: endonuclease III (EcNth) and endonuclease VIII (EcNei) in E.coli, and
by their human orthologs hNTH1 and hNEIL1 (Bandaru, Sunkara, Wallace, & Bond,
2002). In the previous experiments using 3′-Tg substrates, EndonucleaseIII was
successfully used to remove thymine glycol (M. Almohaini et al., 2016). Therefore, in the
current experiments, we used recombinant hNTH1 protein (provided by David Pederson,
University of Vermont) to assay the removal of Tg from the substrates in extract-free
reactions (Fig. 4.1). Initially, hNTH1, at a concentration of 840 nM was added to the
reactions containing the different Tg substrates separately to evaluate the substrate
specificity. Only Tg3 and Tg5 substrates were susceptible to the removal of Tg and not
Tg1 or Tg 2 substrates. In correlation with the extract assays, Tg5 was processed robustly
(79.6%) releasing a product corresponding to 3′-deoxyribose phosphate (dRp)-terminated
14-bp. As expected, the Tg3 was minimally processed with 20.5% of 3′- dRp terminated
16-bp. There were small amounts of 3′-phosphate termini for both the substrates (16P
and 14P). On further treatment of the substrates with TDP1 enzyme, which is capable of
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cleaving various 3′-blocks (Nilsen et al ., 2012), most of the 3′-dRp-terminated termini
were converted to 3′-phosphate termini.
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Fig. 4.1: Recombinant hNTH1-mediated processing of 3′-proximal Tg substrates: A.
Illustration of the ends of different Tg substrates. B. Individual substrates were treated
with 840 nM hNTH1 for 1 hr and then with 10 µM TDP1 for 1 hr before NdeI cleavage and
gel electrophoresis. As observed in the above gel picture Tg5 was more susceptible to
cleavage by hNTH1 than Tg3 (lane 20 vs. lane 16). Figure adapted with permission from
M. Almohaini et al., 2016.
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4.2 Concentration-dependent kinetics of hNTH1:
hNTH1 enzyme was titrated at different concentrations to measure the kinetics of activity
as a function of concentration. When Tg3 and Tg5 were incubated in reactions with the
increasing amounts of hNTH1, there was a steady and rapid increase in processing of
the Tg5 substrate. Even though an increase in Tg3 processing was also observed, it was
less effeciiently processed than Tg5. Percentage of removal of Tg was plotted as a
function of hNTH1 concentrations in Fig. 4.2B. While the total processing of Tg3 substrate
was 78 ± 1.2%, Tg3 processing was 24 ± 0.42%. These observations suggest that Tg at
the fifth position is a better substrate than at the third position for the BER. Further, when
TDP1 was added to the reaction, there was a visible cleavage of 3′-dRp for Tg5 substrate
as shown in the leftmost lane of the Fig. 4.2A. This extensive excision of Tg5 substrate
by base excision pathway in the extracts might have compromised end-joining of the
substrate.
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A.

B.

Fig. 4.2: Purified hNTH1 mediate Tg cleavage from 3′-Tg3 and 3′-Tg5 substrates: A.
The Tg5 (left) and Tg3 (right) substrates were treated with the indicated concentrations
of hNTH1 for 1 h, th cut with NdeI before denaturing gel electrophoresis. Additional
treatment of the substrate with TDP1 removed the 3′‐dRp as shown in the leftmost lane
in Tg5 processing. B. Comparison of Tg cleavage for the Tg3 and Tg5 substrates as a
function of hNTH1 concentrations. Figure adapted with permission from M. Almohaini et
al., 2016. (n = 3)
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4.3 Effect of 5′-end Tg in end-joining of blunt double-strand breaks (DSB):
Since the experiments with the substrates possessing Tg at various
positions at the 3′ blunt end have given interesting results, we pursued the same
experiments with substrates having Tg at the 5′ of the blunt end at either second (5′-Tg2)
or a third position (5′-Tg3). Unlike the previous substrates which were labeled internally
on 3′-strand, the 5′-substrates were radiolabeled at the 5′-terminal phosphate. Therefore
loss of radioactivity as a result of processing in the cell extract experiments was a sign of
Tg cleavage. These substrates were incubated in Bus cell extracts with (Fig. 4.3) and
without XLF (Fig. 4.5) for 6 hours and processed similarly to that of 3′-Tg substrates.
Upon incubation, there was a discernable amount of end-joining for both of these
substrates as evidenced by the radioactive Head-to-Tail end-joining (38-bp) fragment on
the gel. This was in contrast to the absence of any end-joining for the 3′-Tg2 substrate,
and was only two-fold different from the 5′-Tg3 end-joining, 7 ± 1.2% vs. 12 ± 2.7% (Fig.
4.3 B lane 5 vs. lane 7), considering its proximity to the ends. These results suggest
compatibility of 5′-Tg, even when at the second position, for the Head-to-Tail end-joining
as evidenced by the retained radioactivity. Further, there was no Head-to-Head end joing
(36-bp) of these substrates, probably due to the strong hindrance of Tg presence at both
the ends of DSB. However, there was a smaller amount of 22-25-bp end joining products
(lane 5 and lane 7) for both the substrates probably due to a possible induction of
resection at one of the ends owing to the presence of Tg at both the ends, with intact one
end preserving the radioactive label. Nonetheless, there appears to be retention of most
of the radioactivity for both the 5′-Tg substrates as seen by the similar intensity of bands
collectively in both cells extract free (Fig. 4.3B lane 3, and 5) (Fig. 4.6A lanes 4 and 7)
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and added samples (Fig. 4.3B lanes 4 and 6 ) (Fig. 4.6A lanes 5,6,7 and 9 ), suggesting
a less removal of Tg relative to 3′-analogs.
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Fig. 4.3: Effect of 5′‐proximal Tg on NHEJ in Bus cell extracts with XLF: Substrates
with Tg as the second or third base from the 5′ terminus at the blunt labeled end were
incubated for 6 h in XLF-complemented Bustel extracts. A) Illustration of the substrates
and head-to-tail ligation products. B. Denaturing gel analysis of end joining products
following cleavage with NdeI and PstI is expected to release 38-bp Head-to-Tail, and a
36-bp Head-to-Head end joining products. C. Plot of percentage of Head-to-Tail products
observed for the substrates. Figure adapted with permission from M. Almohaini et al.,
2016. (n = 3)
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4.4 Susceptibility of 5′-Tg substrates to processing by recombinant hNTH1:
Similarly to the 3′-Tg substrates, the 5′-Tg substrates were treated with increasing
concentrations of pure protein hNTH1. The release of radioactive fragments was
monitored to measure the function of bifunctional DNA glycosylase. As observed in Fig.
4.4A, there was concentration-dependant release of radioactive fragments from both the
substrates suggesting a Tg cleavage. Maximum release of radioactivity from both of these
substrates by 840 nM hNTH1 was found to be similar (~60%). On comparison, excision
of Tg from the 5′-Tg substrates was lesser than the 3′-Tg5 substrate but was higher than
the 3′-Tg3 substrate (Tg3- ~30%, Tg5- ~80 %, and 5′-Tg2 and 5′-Tg3- ~60%). Total
cleavage from both the 5′-Tg substrates is similar.
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A.

B.

Fig. 4.4: Processing of substrates containing terminally labeled 5′-Tg to by purified
hNTH1: A) The 5′-Tg2 (top) and 5′-Tg3 (bottom) substrates were treated with the
indicated concentrations of hNTH for 1 hr and analyzed on a 36% nondenaturing gel for
the release of the 5′-terminal nucleotide-ribose phosphate from the plasmid substrate. B)
The release of the 5′‐terminal 1- or 2-base fragment measured as a percentage of
radioactivity released into the gel from the well and plotted as a function of NTH1
concentrations. Figure adapted with permission from M. Almohaini et al., 2016. (n = 3)
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4.5 Validation of the above-observed results in cancer cell extracts:
Irradiation is one of the primary treatment modalities used to kill cancer cells, because of
its capacity to cause enormous damage to cellular components, especially DNA. As with
the normal cells, even cancer cells resort to repair these lesions by the retained repair
pathways. To evaluate the repair of Tg lesions in cancer cells, all the above-mentioned
substrates were processed in HCT116 colon carcinoma cell extracts.
4.5.1 Processing of the 3′-Tg lesions in HCT116 extracts:
The 3′-Tg substrates were incubated in HCT116 extracts for 6 hours before being
proteolyzed, ethanol precipitated and treated with restriction enzymes NdeI and PstI (Fig.
4,5). Repair of the substrates in the cancer cell extracts followed a similar trend of endjoining (Tg3>Tg5>Tg2>Tg1) and BER (Tg5>Tg3), as in non-cancer fibroblast cell
extracts, but with a lesser percentage end-joining compared to that of in Bus cell extracts
(Fig. 4.5 vs. Fig. 3.4). There was a formation of the BER product for Tg3 (16-bp) (lane 8)
and Tg5 (14-bp) (lane 10), similarly to Bus cell extracts. As with the Bus cell extracts, Tg5
is processed greater (~22%) than the Tg3 substrate (~4.8%) by BER. And also, this
extensive processing by BER has reduced the Head-to-Tail end-joining of Tg5 substrates
(~3%) compared to Tg3 end joining (~6%). The observed percentages Head-to-Tail endjoining for all the substrates and the BER products of Tg3 and Tg5 substrates were plotted
(Fig. 4.5 B)
4.5.2 Influence of 5′-Tg on the repair of DSB’s in cancer cell extracts:
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Similarly, the 5′-Tg substrates (5′-Tg2 and 5′-Tg3) were incubated in HCT116 extracts
alongside the Bus extracts with or without substituted XLF. As seen in the radiograph of
the gel (Fig. 4.6), there was lesser end-joining of these substrates in HCT116 extracts
than in Bus extracts + XLF ( Fig. 4.6 lanes 4,5,6 vs. 7,8,9). There was more end joining
(1.5 X) of the 5′-Tg3 compared to 5′-Tg2 substrates (Fig. 4.6 B) and corroborating the
findings from Bus cell extract experiments.
These results prove that irrespective of the origin of the cell, the Tg lesions formed in the
promiximity of DSB’s are similarly susceptible to processing. Furthermore, the extensive
processing mediated by BER can interfere with the end joining.

55

B.

A.
B.

C.

1 2 3 4 5 6 7 8 9 10
Fig. 4.5: HCT116 cell extract assays with 3′‐proximal Tg substrates: A) Each of the
3′-Tg substrates were incubated for 6 hr in extracts of HCT116 cells. B) End-joining as
well asTg cleavage, indication of BER were analyzed and plotted. Incresed formation of
BER product is detected with less end joining for Tg5 (lane 10) compared to Tg3 (lane 8).
Figure adapted with permission from M. Almohaini et al., 2016.
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A.

No extract

Extracts
5′ Tg substrates

12 3 4 5 6

789

B.

10

Fig. 4.6 Effect of 5′‐proximal Tg on NHEJ in Bus cell extracts with XLF: A. The 5′Tg2 and 5′-Tg3 substrates were treated with HCT116 whole cell extracts (lanes 7-9), in
addition to Bus extract with (lanes 4-6), and without XLF (lanes 1-3), for 6 hours. B. The
percentage of Head-to-Tail end joining was measured and plotted. (Tg0 = unmodified
ends)
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On the whole, repair of complex lesions, especially those involving strand breaks pose a
complicated scenario requiring an interplay between multiple repair pathways to resolve
the lesion to avoid lethality. It can be hypothesized that in cells there could have been
end-joining of the Tg5 substrates by the resection dependant late NHEJ or alternative
end-joining pathway (Alt-NHEJ) and if progressed to G2, repaired by Homologous
recombination. However, in our extracts when we tried to sequence the end-joining, there
was no evidence of deletions or insertions at least in the 20 samples screened. There can
be two possible reasons for this. The end-joining in these samples was allowed to
progress only for 6 hr and the other processes mentioned above takeover after 6-8 hr.
Moreover, since the experiments were done in a cell-free extract, it might not be possible
to replicate all of the processes occurring in the cells, with a limitation of the activation
and availability of other factors.
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V. Discussion

Oxidative lesions are one of the most common lesions due to radiation, DSB’s being the
lethal amongst them, more so if accompanied by a modified or complex lesion at the
ends. Further, BER enzymes can convert readily repairable or bypassable lesions into
lethal while processing bistranded damage clusters (Harrison, Hatahet, Purmal, &
Wallace, 1998). Radiation can produce strand breaks accompanied by damaged/oxidized
bases. Most commonly oxidized bases are Guanine to 8 –oxo-guanine (8 oxo-G) and
Thymine to thymine glycol (Tg). Previous experiments with 8 oxo-G have suggested it to
be least tolerant when placed at the DSB, at least 4 bases from a 3′end or 6 bases from
a 5′end and when two 8-oxoG lesions are positioned across the break junction, ligation is
severely retarded (Dobbs, Palmer, Maniou, Lomax, & O’Neill, 2008). In the current study,
we wanted to research the tolerability of Thymine glycol at the blunt double-strand break.
Thymine glycol (5,6-dihydro-5,6-dihydroxythymine, Tg), a prototypic pyrimidine lesion
arises from reactive oxygen species attacking either thymine or methyl cytosine. Tg is a
common product of endogenous metabolism, chemical oxidation, or ionizing radiation
(Cathcart, Schwiers, Saul, & Ames, 1984). Unlike 8-oxo-G, the most common purine
oxidative lesion which was shown to be mutagenic, Tg is a lethal lesion as it blocks the
replication. Due to its non-planar structure, the base becomes extra-helical hindering the
stacking of the next 5′ templating residue and inhibiting the next incoming nucleotide,
effectively blocking conventional polymerase-mediated DNA replication. (Robert C.
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Hayes & Leclerc, 1986). However, polκ/polζ and polθ mediate alternate pathways for
promoting replication through a Tg lesion. In the polκ/polζ pathway, following the insertion
of an A opposite TG, polζ would extend from the TG: A base pair. On the other hand, polθ
carry out both steps of TLS, generating ∼5% mutationally altered TLS products (Yoon,
Roy Choudhury, Park, Prakash, & Prakash, 2014). Repair of the thymine glycol lesion
can be by BER, NER and transcription-coupled repair (TCR), hNTH1 and hNEIL1 of BER
playing a major role in excising Tg (Dolinnaya, Kubareva, Romanova, Trikin, & Oretskaya,
2013b).
The current study is an extension to previous observations made in the lab by
Mohammed et al., 2016, positioning Tg at different lengths from the 3′ end of the blunt
double-strand break and study it in the context of NHEJ. It was noted that Tg placed at
the third position allowed for an efficient end-joining compared to the first and second
positions. However, placing Tg at fifth position limited the end joining while producing a
more evident smaller fragment of DNA corresponding to a cleaved product at the Tg. Tg
is a substrate for two BER repair proteins hNTH1 and NEIL1, which removes the lesions
via β-elimination or β,δ-elimination respectively. Although these proteins can backup each
other, they are expressed in a tissue-specific manner (Hazra et al., 2002) (Aspinwall et
al., 1997). To support our hypothesis that there is more base excision repair of Tg5
substrate hindering the end-joining, a pure recombinant NHEJ protein assay was done.
In the absence of other repair factors, we evidenced an increase in the end-joining of Tg5
substrate compared to Tg3 substrate. Further, we wanted to see if Tg5 was a better
substrate than Tg3 for BER by performing a recombinant protein assay with hNTH1. As
expected, hNTH1 repaired Tg5 more efficiently compared to Tg3.
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Next preference of positioning Tg at 5′end for BER was measured by
positioning Tg at the second or third position of the blunt DSB. There appeared to be no
preference in overall processing these substrates.In contrast to the internally labeled 3′
substrates, 5′ substrates are terminally labeled, and the end-joining of these substrates
was evident from the detection of the band which was about 40% and 60% of the
unmodified substrate end-joining for Tg2 and Tg3 respectively. Unlike 3′-Tg at a second
position which allowed for minimal end-joining, 5′-Tg at second position allowed for
considerate end-joining, with Tg in position.
All the above experiments were performed in Bustel fibroblast extracts which are
inherently deficient in XLF, an end-joining protein, to study its role in NHEJ. To validate
the observations made in these extracts and also to study the repair of Tg lesions in
cancer cells which could be a result of radiotherapy, processing of Tg lesions was tested
in HCT116 cell extracts. Even though the overall end joining seen in these extracts is less
compared to Bus cell extracts, the profile of the repair of Tg lesions appeared to be similar.
Extensive nucleolytic excision of the 5-base 5′-overhang of the complementary resulting
from the BER might have limited the end-joining of the Tg5 substrates in both the extracts
(Fig. 3.2 vs. Fig. 4.5). Similarly, there was appearance of the unjoined BER product of
Tg3 in both the extracts. On the whole, these studies provide evidence that both BER
and NHEJ function hand in hand in the repair of oxidative lesions, with BER interfering
with NHEJ in a lesion dependant manner.
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A.

B.

Fig. 5.1: Proposed model for the interference by BER in NHEJ : A) When base
excision repair proteins recognize and remove the Tg from the third position in Tg3,
instead of the 19- bp fragment 16-bp fragment was formed and there was no end joining
of the fragments. B) When the Tg from the Tg5 substrate was removed, there was the
formation of 14-bp fragment, and there was no end joining.
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Chapter 2

RESOLUTION OF DNA 3′-PHOSPHATE ENDS IN THE ABSENCE OF PNKP AT THE
FREE
RADICAL-MEDIATED
DNA
DOUBLE-STRAND
BREAKS
FOR
NONHOMOLOGOUS END JOINING

VI. Introduction

A feature of ionizing radiation resulting from its mode of energy
deposition is a generation of a high local concentration of free radicals producing complex
DNA lesions, two or more lesions within 1–2 helical turns of DNA, which may involve
strand breaks. DNA strand breaks are also a consequence of DNA damage due to
chemotherapy, metabolic oxidative process or during repair of the complex lesions by the
repair machinery. These strand ends are rarely clean with a variety of chemical
modifications and are non-compatible for re-ligation. 3′- phosphate and/or 5′- hydroxyl
ended SSB’s or DSB’s can be a direct result of the insult or as an intermediate during
processing of the base damage or overhang 3′-phosphoglycolate end by NEIL enzymes
and TDP1, respectively. PNKP is a bi-functional enzyme with a DNA 5′- kinase and 3′phosphatase function that restores the strands conventional compositions –i.e., a 3′hydroxyl and 5′- phosphate ends.PNKP was the first gene for a DNA-specific kinase from
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any organism and the second gene for a mammalian DNA 3′-phosphatase to be identified
(Jilani et al., 1999) PNKP plays a crucial role in processing both single strand, and double
strand breaks, enabling them to be filled in and ligated by DNA polymerases and DNA
ligases, respectively. Because of its ubiquitous role in repair of the DNA, PNKP is being
considered as a potential target for chemotherapy. Stable down-regulation of PNK in
human cells results in hypersensitivity to a number of DNA damaging agents including
ionizing radiation, camptothecin, and H2O2 and also increases the spontaneous mutation
frequency (Rasouli-Nia, Karimi-Busheri, & Weinfeld, 2004). Studies have also shown that
PNKP’s role as a party of NHEJ is essential for the normal neurological development of
the organism (Dumitrache & McKinnon, 2017) (Bras et al., 2015) (Reynolds, Walker,
Gilmore, Walsh, & Caldecott, 2012). These studies showed that knockout of PNKP
resulted in lethality while the mutations induced developmental delay of the CNS.
6.1 Polynucleotide kinase phosphatase
6.1.1 Structure:
The domain-mapping experiments, sequence analysis, and crystallography studies have
revealed a three domain molecular structure - Kinase, Phosphatase and Fork Head
Associated domains (FHA) for the PNKP protein. The phosphatase (Gly 145–Glu 336)
and the kinase (Phe 340–Glu 521) catalytic domains are linked flexibly to an
aminoterminal phosphoprotein-binding forkhead-associated domain (Ser 6–Ser 110)
(Bernstein NK et al., 2005). This flexible organization of the FHA and catalytic domain
was revealed by the trypsin digestion which releases a 40 kDa (catalytic domain) and 14
kDa FHA domain. The interdomain linker (Leu 337–Ala 339) and the C-terminal residues
Gln 518–Gly 522 pack against helix 5 and the β12-α4 loop of the phosphatase prohibiting
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the separation by proteolysis. The phosphatase domain which encompasses 136 to 337
residues has a structure typical of the haloacid dehalogenase (HAD) superfamily, which
includes β-phosphoglucomutase (β-PGM), phosphoserine phosphatase (PSP), P-type
ATPase and RNA polymerase II CTD phosphatase (Aravind, Galperin, & Koonin, 1998).
Although there is low sequence similarity between these proteins, there is a conserved
motif Dx(D/T)x(T/V), where the first Asp (170 in mPNK) forms the covalent
phosphoaspartate intermediate. Serine or threonine (216), a lysine (259), and a pair of
aspartates (288 and 309) are the other conserved residues, all of them located in the
HAD α/β domain (Bernstein NK et al., 2005). Despite structural variations among the α/β
domains, the active site configuration is exquisitely preserved.
The kinase domain is of 189 residues and belongs to the adenylate kinase
family and consists of a 5-stranded parallel β sheet, common to GTPases and P loop
kinases (Leipe, Koonin, & Aravind, 2003) (Leipe et al., 2003), and is flanked by helices
on both sides. Also, there are three helices (α12, 13, and 15) which lie between the α/β
sandwich and the phosphatase domain. The kinase active site is located in a long cleft
and similar to other ATP binding sites, it has a conserved Walker A and B motifs. The
protein-phosphoprotein

interaction

motif, FHA,

has

a

high

specificity

for

phosphothreonine (pThr) residues. Structurally, it possesses the typical β sandwich fold
consisting of a 3-stranded and a 4-stranded antiparallel β sheets. The N- and C termini
of the domain are located on adjacent β strands, and loops bind the phosphopeptide on
the opposite side of the domain. There is a conserved motif S47RNQ50 that forms a
protruding U-turn shape preceding the β5 strand, and the recognizes of phosphopeptide
by a conserved Arg (Arg70) and Ser (Ser85) residues and nonconserved Arg48 residue.

65

Among the domains of the protein, FHA domain is poorly ordered, allowing for the
flexibility of the catalytic domain.
6.1.2 Substrate specificity, recognition, and function of PNKP:
Each catalytic domain has its preference for the substrate. The kinase domain of PNKP
preferentially phosphorylates the 5′ end of DNA at the nicks and small gaps (KarimiBusheri & Weinfeld, 1997) and a duplex of at least 8 nucleotides with a 3′-overhang of ≥
three nucleotides (Bernstein et al., 2009). The kinase active site located in the deep cleft
with ATP binding site on one side and the DNA substrate binding site on the other. The
substrate binding site has two positively charged surfaces, one flanking the Asp 396,
which acts as a general base to activate 5′-OH group in the duplex. The phosphate group,
3′ to the 5′OH end, is stabilized by Thr 423, and no contact is made with the protein by
the substrate until 6-8 nucleotides on the complementary strand upstream around Arg
403, consistent with the substrate requirement. The other side of the cleft surface consists
of Arg482 and Lys483 which interact with the four backbone phosphate groups of the
single-stranded 3′ overhang downstream of 5′ OH strand, explaining the minimal length
requirement for the 3′ overhang.The Aspartic 396 interacting with the 5′-OH group of the
substrate forms general base assistance for the nucleophilic attack on the ATP γphosphate, with the aid of Mg2+, resulting in the phosphorylation of the 5′-end.
In contrast to the kinase domain, the phosphatase domain accepts a broad
range of substrates including nicked, gaped DSB and oligonucleotides of short segments
5′ to the 3′-phosphate. The phosphate group at the active site in the conserved motif
Dx(D/T)x(T/V), is stabilized by, Mg2+, Lys 259, Thr 216 and main chain NH of Leu171.
There is an in-line nucleophilic attack on Asp170 producing a phospho-intermediate and
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a leaving group. The release of phosphate from the phosphointermediate is catalyzed by
Asp 172 which functions as a general acid by protonating the alcohol leaving the group
(Bernstein et al., 2008). However, the narrow, deep active cleft can accommodate only
single but not the double strand substrates. To access the phosphate group in doublestranded substrates, PNKP needs to unwind the DNA with the help of its conserved basic
surface. While the Phe 184 forming “the Phe wedge,” plays a critical role in the initiation
of base-pair destabilization through hydrophobic interactions with the substrate bases,
Phe305, buried in the active site, could play a role in stabilizing the liberated single-strand
in the catalytic conformation through stacking interactions with the 3′-terminal base.
Recognition and interaction of the penultimate base are also crucial for binding and
activity of the enzyme. Lys184 and β13-α6 loop (residues 300–303), away from the
active site engage with the partner strand in the double-stranded substrate before
destabilization, providing additional binding energy, and with the complementary
undamaged strand after base-pair destabilization. This stabilization of the complementary
strand is required to compensate for the unfavorable free energy associated with basepair disruption (Coquelle, Havali-Shahriari, Bernstein, Green, & Glover, 2011).
Fluorescence Spectroscopic Studies of 2AP-Modified DNA Complexes have shown that
the destabilization of the double-stranded DNA substrate was maximum up to 2 terminal
bases with partial destabilization up to 8 terminal bases (Coquelle, Havali-Shahriari,
Bernstein, Green, & Glover, 2011). The FHA domain of the PNKP recognizes the CK-2
phosphorylated phosphothreonines on XRCC1 and XRCC4, directing PNKP towards
either single strand or double strand breaks, respectively.
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The phosphatase activity of the enzyme takes precedence over and has a
faster catalytic rate than kinase activity (Dobson & Allinson, 2006). This precedence of
phosphatase over kinase activity may be due to protecting the DNA from the most
common damage induced by radiation or by bifunctional glycosylases, i.e., 3′-phosphate
formed more commonly than the 5′-hydroxyl ends.Given the limited flexibility between the
catalytic domains, there is a sequential repair of the DSB substrates having to possess
both 3′-phosphate and 5′-hydroxyl ends. There are a preferential binding and processing
of the 3′-phosphate, kinase activity being almost stoichiometrically inhibited by the 3′phosphorylated competitor (Dobson & Allinson, 2006). There appears to be interdomain
cross-talk between the two active sites since the ablation of the 3′-phosphatase activity
blocks the 5′-kinase activity. Presence of a 3′-phosphate end prevents phosphorylation
at the 5′-end and premature conversion to 5′-phosphate end, which would result in an
abortive ligation attempt by the DNA ligases adding an adenylate group to the
phosphorylated end (Ahel et al., 2006a). Further, the presence of a 5′-hydroxyl block can
be theoretically bypassed by extending the 3′ hydroxyl strand and by the removal of 5
hydroxyl flap by FEN, which leaves a 5′ phosphate, allowing for the successful ligation
(Dianov, Sleeth, Dianova, & Allinson, 2003).
6.1.3 Role of PNKP in strand break repair:
For ligation and extension of the of the DNA ends, 3′ hydroxyl and 5′-phosphate ends are
imperative. PNKP’s function as a DNA 3′-phosphatase is crucial in achieving the strand
integrity. Hence, PNKP participates in repairing various SSB’s/DSB’s caused due to drugs
such as Bleomycin, during BER, and NHEJ. Depending on the repair pathway, PNKP is
seen to interact with various proteins in the repair complex. In NHEJ, PNKP is shown to
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form a complex with XRCC4 in dual modes, with non-phosphorylated via FHA domain or
phosphorylated (pXRCC4 via the catalytic domain (Fig.5.1) Interacting with XRCC4 alone
enhanced the 5′ kinase activity on the DNA ends, only to be slightly increased by
XRCC4/LigaseIV. However, interacting with pXRCC4 inhibited the activity which was
reversed by the pXRCC4/LigaseIV complex (Mani et al., 2010a). Small angle X-ray
scattering (SAXS) structural studies have shown that there is flexible tethering of PNKP
to XRCC4 via the FHA-phosphopeptide interaction, adopting a compact conformation
which allows for the dynamic interaction between the PNKP catalytic domain and the Nterminal structured region of XRCC4 and/or the LigIV BRCT domain (Aceytuno et al.,
2017a). Depriving of this later interaction due to an E326K mutation in human cells
reduces PNKP recruitment to sites of UV laser-induced DNA damage and is associated
with a severe form of the neuro-developmental disorder termed MCSZ (Shen et al., 2010).
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A.

B.

Fig. 6.1: PNKP structural representation: A. Ribbon diagram of mammalian PNKP with
kinase domain represented in yellow, phosphatase in blue and FHA domain in green, with
ATP binding P-loop in navy blue. Figure adapted with permission from Bernstein et al.,
2005. B. Schematic representation of PNKP domains with labeled XRCC4/XRCC1
interacting regions on PNKP.
Figure adapted with permission from
Allison 2010.
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Hypothesis

There are alternatives to Polynucleotide kinase phosphatase enzyme (PNKP) which can
process DNA 3′-phosphate and 5′-hydroxyl ends in its absence

Background:
PNKP enzyme converts DNA 3′-phosphate and 5′-hydroxyl ends to 3′-hydroxyl and 5′phosphate ends, enabling strand extension and/or ligation. . There has been no other
factor identified to compensate for the loss of PNKP. However, when PNKP was
knockdown or pharmacologically inhibited there was no difference in processing of the
DNA 3′-phosphate ends produced by treatment of HCT116 cells with Neocarzinostatin
(NCS), as detected by Ligation-mediated PCR (LM-PCR). Therefore, to further study the
effects of loss of PNKP, PNKP knockout cells were used to study processing of the
specific substrates, in the context of NHEJ, in the extracts. Also, we also elucidated the
role of core NHEJ factors in the processing of these substrates.
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6.2 Specific aims:

1: To evaluate the processing of DNA 3′-phosphate DSB substrates in wild-type and
PNKP knockout extracts to determine whether there are alternative DNA 3′phosphatases and whether they function in the context of NHEJ
2: To identify the presence of DNA 5′-kinases in the HCT116 PNKP knockout extracts
3: To determine the role of XRCC4 and XLF in processing DNA 3′-phosphate and 5′hydroxyl substrates
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VII. Material and Methods

7.1 3′-phosphate substrate
Oligonucleotides with 3′-phosphate, 3′-phosphotyrosyl ends, and 5′-hydroxyl ends are
acquired from Midland labs (Texas). They were re-suspended in TE (10 mM Tris–HCl,
pH 8, and 0.1 mM EDTA). 1 mCi of [γ-32P] ATP was used to label 50 pmoles of the
oligonucleotide, using Polynucleotide kinase (PNK) and incubated for 1 hr at 37 °C.
7.2 Preparation of pRZ56 and ligation of oligomers to the MluI cleaved pRZ56
The polylinker region of pSV56 plasmid was excised as a 625-bp PflMI/AvrII fragment,
and cloned into pBR322 between the EcoRV and NheI sites (the PflMI cut was bluntended with T4 polymerase), to create a 5-kb pRZ56 plasmid. 76 μg of the plasmid pRZ56
DNA was linearized with 100 units of MluI (NEB) in 0.3 ml of NEB buffer 3 for 2 hr at 37
°C and was ethanol precipitated. 10 μg of the linearized plasmid was then subjected to
controlled 3′ → 5′ exonucleolytic digestion with five units of T4 polymerase (NEB), 1 mM
dTTP in a buffer containing 33 mM Tris-acetate pH 8, 66 mM potassium acetate, 500 μM
DTT 100 μg/ml BSA at 11 °C for 2 hr. The plasmid was proteolyzed and ethanol
precipitated and resuspended in 40 μl TE after drying. This procedure results in a 10base 5′ overhang at one end and an 11-base 5′ overhang at the other due to resection at
each 3′-terminal strand to the first thymine in the sequence. 5 picomoles of an unlabeled
13-mer and a 5′-32P-labeled 14-mer with a 3′-phosphate, or an unlabelled 9-mer and a 5′73

32P-labeled

10-mer with a 3′-phosphate or an unlabeled 13-mer and a 5′-32P-labeled 14-

mer with a 3′-phosphotyrosyl, each complementary to its 5′ overhangs, were successively
ligated with 60 units of T4 DNA ligase, in 1X Ligase buffer in a 50 μl reaction for overnight
at 16 °C to specifically labeled substrates with partially complementary (-ACG) overhangs
or recessed ends. These substrates were purified on a 0.8% agarose gel, electroeluted
and concentrated with an Ultracel 100k centrifugal filter.
7.3 Construction of 5′-hydroxyl substrates:
5′-CCGGGGACCTGCGTACGTGTTC

and

3′-CCTGGACGCATGCAC-OH,

complementary oligonucleotides were ordered from Midland Labs, Texas and resuspended in TE (10 mM Tris–HCl, pH 8, and 0.1 mM EDTA). They were annealed in
equal quantities, via heating to 80 °C followed by slow cooling to 10 °C. The duplexes
generated by this annealing process resulting in 3-base 3′overhang on one end with a 5′hydroxyl group in the complementary strand, and a 4-base 5′ overhang on the other end
that is complementary to the 5′ overhang created by XmaI digestion of pUC19.
7.4 Ligation of oligomeric duplexes to the XmaI cleaved pUC19:
20 μg of the pUC19 plasmid DNA is digested with 100 units of XmaI (NEB) in 0.7 ml of
NEB Cut Smart buffer for 3 hr at 37 °C. 7 μg of the cut plasmid is treated with 10 units of
CIP in 2.4 μl of CutSmart buffer for 1 hr at 37 °C in a total reaction volume of in 20 μl. The
linearized fragment was ethanol precipitated and was radiolabeled with 6 μl 1 mCi γATP
and 3 units of T4PNK for 45 minutes in 37 °C, which was ethanol precipitated again. The
precipitate was dissolved in 40 μl of TE, and to this, 20 μM, oligo duplex with 5′-hydroxyl
end was ligated with 800 units of T4 ligase in 5 μl of T4 Ligase Buffer, in a total reaction
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volume of 50 μl, at 16 °C overnight. The resulting substrate had two recessed 5′-hydroxyl
ends and labeled on both ends.The ligation products were purified by 0.8 % agarose gel
electrophoresis and Electroelution.

7.5 Electroelution of the modified substrates:
The nucleotide is electroeluted using an 11-inch segment of pretreated dialysis tubing
(6,000-8,000 molecular weight) filled with the buffer composed of 20 mM Tris, pH8 and 1
mM EDTA (the elution buffer). The gel slice containing the desired DNA band was placed
in the dialysis tubing, and the other end of it was knotted after removal of air bubbles. The
dialysis tube was placed in a gel box filled with the same buffer, and the DNA was eluted
overnight at 50 V. Then the dialysis bag was cut, and the buffer containing DNA substrate
was collected into 15 ml centrifuge tubes. 0.45μm filters were used to remove any debris,
and the DNA was concentrated by micro- concentration to about 500 μl using centricon100 (Amicon). The concentrate was collected into 1.5 ml Eppendorf tubes and
precipitated with 1/9 volumes of NaOAc and 2.5 volumes of 100% EtOH, washed with
70% EtOH and dissolved in 50 μl TE.
7.6 HCT 116 and HeLa cell extracts preparation:
HCT116 and HeLa, Wildtype (WT) and PNKP CRISPR knockout cells (PNKP-/-), cells
were kindly provided by Dr. Weinfeld, Cross Cancer Institute, Alberta, Canada. These
cells were grown to 70% - 90% confluence on 15-cm dishes each with 15 ml RPMI media
with 10% FBS. Then they are serum starved for 4 days with 15 ml of .5% serum. On the
day of the experiment, the dishes were washed with 20 ml PBS at room temperature. 3
ml of 0.25% trypsin-EDTA was added to each dish, making sure it covers all the cells.
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They were incubated for 5 min until the cells are detached and then 3 ml medium and
serum was added. These samples were collected and pelleted in 50 ml tubes at 1500
rpm for 5 min in ultracentrifuge using SW55 rotor at room temperature. The cells were
resuspended in 50 ml medium and serum and pelleted again. The pellet was again
resuspended in 25 ml medium and serum and pelleted again. The pellet was
resuspended in 30 ml ice-cold PBS and pelleted at 4 °C and packed cell volume (PCV)
was recorded. The last process was repeated again. The pelleted cells were resuspended
in 5XPCV cold hypotonic buffer containing10 mM Tris-HCl pH8, 1 mM EDTA, 5 mM DTT
and proteinase inhibitors pepstatin 1 μg/ml, chymostatin 1 μg/ml, aprotinin 2 μg/ml,
leupeptin 1 μg/ml, PMSF 1 mM. The cells were quickly pelleted. This pellet was again
resuspended in 2XPCV hypotonic buffer and inhibitors and let set on ice 20 min. 1.5 ml
of this solution was put in a small dounce homogenizer each time and stroked 20 times.
After it was let set for 20 min, it was transferred to cold 5 ml centrifuge and ¼ volume of
the hypertonic solution ( 83.5 mM Tris pH 7.5, 1.65 M KCl, 3.3 mM EDTA, 1 mM DTT)
and inverted several times to mix well. This was centrifuged at 43K for 3 hr in SW55 at 2
°C. From the top the middle layer which has cytosol was collected using 22G needle,
avoiding cloudy layer on the top. The cytoplasm thus collected was dialyzed for 3 hr in
storage buffer (20 mM Tris pH 8, 0.1 M KOAC, 1 mM DTT, 0.5 mM EDTA, 20% glycerol)
with inhibitors at 4 °C. The resulting solution was frozen in small aliquots(10 μl - 80 μl) at
-80 °C.
7.7 3′-phosphatase, 5′-kinase and end joining assays using cell extracts:
HCT116 Wildtype (WT) and PNKP knockout, HeLa Wildtype (WT) and PNKP knockout,
Bustel whole cell extracts (with/without 200 nM recombinant XLF) and HCT116 XRCC476

/-, were used for the reactions in a buffer containing 50 mM triethanolammonium acetate
(pH8), 1 mM ATP, 1 mM dithiothreitol, 50 μg/ml BSA , 1.3 mM Mg(OAc)2 and dNTPs at
100 μM each.
The total reaction volume was 16 μl, with 10 μl or 11.5 μl of extract, resulting in a final
protein concentration of 12.5 mg/ml. 20 ng of the substrate was added and the reaction
mixed by pipetting and incubated at 37 °Cfor various times as mentioned. In reactions
with Bus cell extracts, 200 nM XLF was added to some reactions. XRCC4 knockout
extracts were substituted with either 0.6 μg of pure XRCC4/LigaseIV or 30 ng of PNKP.
In some reactions, the extracts were pre-incubated for 10 min with 0.2 μl DNA-PKcs
inhibitor, NU7441, dissolved in DMSO, at the indicated concentrations. After certain
incubation times, samples were deproteinized by adding an End Joining Lysis buffer
containing, 1% SDS, O.3 M Nacl, 20 mM Tris HCL pH 7.6, 10 mM EDTA and 1 mg/ml of
Proteinase K for 3 hr at 56 °C. The DNA was then precipitated with glycoblue and ethanol
for one hour. After the precipitation, all samples were dissolved in 21 μl of TE and digested
with 10 units of BstXI/AvaI and TaqαI and 2.5 μl of 10X CutSmart buffer (New England
Biolabs) at 37 °C for 3 hr. Gel electrophoresis of the samples was done in 20%
polyacrylamide sequencing gels. Then the gels were exposed to phosphoimaging screen
for 1 or 2 days at -20 °C. Data were analyzed using a Typhoon 9100 imager (GE
Healthcare Bio-Sciences, Pittsburgh) and Image Quant 3.1 or 5.1 software (GE
Healthcare Bio-Sciences, Pittsburgh). The percentage of 3′ phosphatase, 5′-kinase and
end joining was determined by measuring the percentage radioactivity of the joined
fragments as a function of total radioactivity in the same lanes
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7.8 Nuclear and Cytoplasmic fractionation and Western blot:
HCT116 and Hella cell extracts fractionation was done using a kit from Bio-vision. The
protein in the extracts was quantified by BCA aasay and were normalized to the same
concentration. Laemmli buffer (4% SDS, 20% glycerol, and 120 mM Tis pH 6.8, 10%
BME) was added to the extracts and boiled for 10 min at 90 °C. 50 μg of the protein from
both the extracts were resolved on either a 10% or Any-KD Biorad SDS-Polyacrylamide
gel. Pure PNKP protein, kindly provided by Dr. Weinfield was used as a positive control.
PNKP in was detected by using Mouse monoclonal antibody at 1:5000, against the 1 140 aa epitope (initially to define the knockout status). In the later experiments,
membranes were probed with either a Mouse monoclonal antibody (Santa Cruz) with an
epitope of aa 379-411 (1: 500) or Rabbit polyclonal antibody (1:10,000) (Dr. Weinfeld)
raised for full-length protein. All the primarry antibodies were diluted in 1%Casein in PBS,
added to the membranes incubated overnigt at 4 °C, with rocking. Ater washing the blots
with TBST 10 minutes x 3, the membranes were incubated in 10 ml of respective
peroxidase conjugated (chemiluminiscent) secondary antibodies, recombinant antimouse antibody (Santa Cruz) at a concentration of 1:1000 and goat anti-rabbit (Cellsignalling) at a concentration of 1:3000, in 1% Casein in PBS, for one hour at room
temperature. After washing the membranes with TBST 10 minutes x 3, ECL Thermoscientific Fischer substrates were added to develop an X-ray or image using Biorad
imager.Thermoscientific Fischer Supersignaling western blot enhancer kit was used for
the antibody from Santa Cruz, to increase the sensitivity of detection. Image J was was
used for the quantification of the bands.
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7.9 Nuclear extract 3′-phosphatase reactions:
Nuclear extracts of HCT116 and HeLa extracts were assayed for the phosphatase activity
in a reaction similar to whole cell extracts, at 2 mg/ml concentration of nuclear protein and
a buffer containing 50 mM triethanolammonium acetate (pH8), 1 mM ATP, 1 mM
dithiothreitol, 50 μg/ml BSA , 1.3 mM Mg(OAc)2 and dNTPs at 100 μM each. 20 ng 3′phosphate overhang substrate was incubated in these reactions incubated at 37 °C for
various times as mentioned, which were then proteolyzed, ethanol precipitated and cut
with AvaI to be analyzed on a 20% PAGE.
7.10 PNKP inhibitor assay:
ST042146, a 3′ phosphatase inhibitor was dissolved in DMSO at a stock concentration of
50mM and different dilutions of 10 mM, 1 mM, .4 mM and .1 mM were made in separate
tubes. They were incubated overnight at 72 °C, which darkened the drug solutions. PNKP
inhibition assays were performed on either a PNKP pure protein (100ng), or 1:125
(HCT116) or 1:100 (HeLa) WT and PNKP knockout extracts diluted in PNKP storage
buffer (50 mMol/L Tris-HCl (pH 7.4), 100 mMol/L NaCl, 5 mMol/L MgCl2, and 0.5 mMol/L
DTT). 100ng of PNKP pure protein was added to a 20 μl reaction with 1X phosphatase
buffer (50 mMol/LTris-HCl (pH 7.4), 0.01 mMol/L EDTA, 0.1 mMol/L spermidine and 2.5
mmol/L DTT). For the extract assays, the diluted whole cell extracts were added to the
above phosphatase buffer in a total reaction volume of 16 μl. Before adding the 3′phosphate substrate to these extracts, the reactions were incubated with DMSO or
ST042164 to a final concentration of 20 μM or 50 μM, for 10 min at 37 °C. 20 ng of the
substrate was added to each of these reactions and incubation was continued for 1 hour
at 37 °C. Later the samples were proteolyzed and processed similarly as above.
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7.11 Polyacrylamide gel electrophoresis:
For electrophoretic separation of the DNA strands, Polyacrylamide gels (20x30x0.08cm)
containing 40% acrylamide: bisacrylamide in a ratio of 20:1, 8 ml of 10XTBE and urea in
a final concentration of 8.3 M ina total volume of 80 ml, were used. The mixture was
cooled to room temperature, and 0.06 g ammonium persulfate and 45 μl of TEMED (N’,
N,’ N,’ N’-tetramethylethylene diamine) were added. The gel was allowed to polymerize
for 1 hour. 15 μl of samples are then loaded into the wells of the gel and electrophoresed
at a constant power of 42 W until the marker reached the bottom of the gel.
7.12 Statistics:

Error bars represent standard error of the mean (SEM) for at least two independent
experiments. Unpaired two-tailed t-tests and ANOVA were performed as required and the
data was reported as significant if p values <0.05.
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Fig. 7.1: Western Blot confirming the PNKP knockout: WT and HCT 116 cell nuclear
extract and cytoplasmic extracts were fractionated using BioVision Nuclear/Cytosol
Fractionation Kit and were resolved on a 10% SDS-PAGE, which was botted on to a
nitrocellulose membrane, and probed a mouse monoclonal antibody targetting aa 1-140
on the N-terminal end and was detected using a secondary anti-mouse peroxidase
labeled antibody. Vinculin was used as a loading marker for a cytoplasmic fraction, while
the non-specific band in the nuclear extract fraction was considered as a loading control.
As seen in the lane 2 from the left, there was no band corresponding to PNKP in the
PNKP knockout nuclear extract
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Fig. 7.2: Designing 3′-phosphate double-strand DNA break substrates: Illustration of the
synthesis of a 3′-phosphate substrate by ligating different P32- labeled oligonucleotides into
the MluI cut and processed pRZ6 5′ overhangs to create an internally labeled substrate (3′
overhang is shown for example). B. Three different substrates, 3-base partially
complementary overhang substrate, 2-base recessed substrate with a 3′-phosphate and a 3′base partially complementary overhang substrate with a phosphotyrosyl group are shown.
For convenience, the labeled end is designated as the Head and the other end as Tail.
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VIII. Results

Ionizing radiation and genotoxic agents often generate strand breaks with
incompatible termini that must be processed by the repair pathways for chain extension and
ligation. Some frequently occurring blocks are 3′-phosphate or 3′-phosphoglycolate ends, and
more rarely, 5′-hydroxyl ends. The 3′-phosphoglycolate ends are processed by TDP1, APE1,
and Artemis (Menon & Povirk, 2016). The only known and confirmed enzyme that processes
3′- phosphate and 5′-hydroxyl ends is polynucleotide kinase phosphatase (PNKP). Although
its involvement in promoting cancer development is not elucidated, its role in normal
neurological development has been extensively explored (Shimada, Dumitrache, Russell, &
McKinnon, 2015).
Like other DNA repair factors, PNKP loss leads to disruption of neurological
development resulting in diseases such as oculomotor apraxia (Bras et al., 2015). PNKP plays
a crucial role in the repair of strand breaks, both single and double, thus taking part in pivotal
DNA repair pathways. This ubiquitous role of PNKP along with the lack of any other identified
redundant factor to replace it, makes it a very attractive target for the treatment of cancer.
Many small molecule inhibitors of PNKP were identified and tested to be used as a cancer
therapy sensitizers (Freschauf et al., 2009). Therefore, the current study is done to explore
the presence of alternative DNA 3′-phosphatases and 5′-kinases in the cell, which might have
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the capacity to compensate for PNKP loss and promote resistance to PNKP inhibition. Two
basic approaches to conduct the study are to either deplete PNKP or inhibit PNKP activity.
Nevertheless, experiments with PNKP knockdown cells and the PNKP inhibitor
(A12B4C3) have shown little difference in processing of the 3′-phosphate ends produced by
the treatment of HCT116 cells with 5 μM neocarzinostatin (NCS) which introduces 3′phosphate and 3′-phosphoglycolate DNA strand breaks . Hence, to completely eliminate any
residual activity of PNKP, we acquired PNKP knockout cells from Dr. Weinfeld’s lab. Whole
cell extracts (WCE) were made from the HCT116 wild-type and the knockout cells, and and
32P-Internally

labeled substrates with either a 3′-phosphate end or 5′-hydroxyl end were

generated to test their processing in extracts, as described in the Methods section. In addition,
HCT116 XRCC4 knockout and Bustel fibroblasts (XLF deficient) WCE were made to study
their role in processing of the above substrates.
In parallel, the PNKP knock-out status was confirmed using an antibody provided by
Dr. Weinfeld. As shown in Fig. 6.1, there was no band corresponding to PNKP in western
blots of nuclear extracts of PNKP knockout cells when a monoclonal antibody detecting Nterminal amino acids 1 - 140 was used as a probe. Furthermore, treatment with the drug NCS
reduced the survival of PNKP knockout cells more than the wild-type cells. Also, the NHEJ
repair foci measured as a function of the number of 53BP1 foci persisted in the knockout cells
even after 8 hr, when all the foci in WT cells have disappeared. Considering the above results,
we proceeded to perform in-vitro extract experiments to evaluate the removal of a phosphate
from the 3′-end or phosphorylate the 5′-end, allowing for the fill-in and end-joining of a DSB.
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8.1 Processing of the DNA 3′-phosphate overhang and recessed ends:
PNKP processes 3′-phosphate and 5′-hydroxyl ends at both single and double strand breaks
of the DNA (Weinfeld, Mani, Abdou, Aceytuno, & Glover, 2011). In the current experiments,
we wanted to explore the consequences of the loss of PNKP in processing different DSB
substrates in the context of NHEJ. To assess the same, substrates with either a 3-base
partially complementary 3′-overhangs or a complementary 3′-recessed ends with a 3′phosphate on one end were incubated separately, in either WT or PNKP knockout extracts
for different times.
As shown in the figure 8.1, there will be removal of 3′-phosphate from the substrates by
PNKP in the wild-type extracts, thereby leading to end-joining of some strands. We wanted to
observe if the same would happen in the absence of PNKP. When the conversion of the 3′phosphate end to a 3′-hydroxyl end was measured as a function of time, when incubated in
the extracts, wild-type HCT 116 cell extracts were able to remove about 50% of the 3′phosphate in the first 5 min and convert all the 3ʹ-phosphate into 3ʹ-hydroxyl within 45 min of
incubation, while the PNKP knockout extracts showed a delayed (10X) and incomplete (76.7
± 1.80%, n = 4) removal even at the end of the total period of incubation (6 hr), from the
substrates with partially complementary 3ʹ overhangs (Fig. 8.2 A). Phosphate removal from
the substrates with recessed 3′-ends on both sides, with 3ʹ-phosphate on one side, was
incomplete ( 83.6 ± 4.06%, n = 3 ) even in wild-type cell extract, while most of the phosphate
(70.9 ± 4.38%, n = 3), was retained in PNKP knockout extracts (Fig. 8.3 A).
As the time progressed some of the ends were joined either Head-to-Tail or Headto-Head, with a fill-in (T) reaction (Fig. 8.1 A) occuring at the partial complementary –ACGp3′ overhangs. When this end-joining of the substrates was quantified, there was an increase
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of joining observed for both the substrates with incubation time, in both WT and PNKP
knockout extracts, albeit less in the knockouts. The Head-to-Tail end joining (42-bp) was 1.5
± 0.17% (n = 4), and Head-to-Head end joining (24-bp) was 0.95 ± 0.10% (n = 4), for the
overhang substrate in the WT vs 0.84% ± 0.05% and 0.56% ± 0.14%, for the knockouts.
Owing to the complementarity recessed ends were joined effeciently, with a Head- to-Tail end
joining (36-bp) of 3.7 ± 0.79% in WT vs. 2.75 ± 1.23% in knockout extracts (n =3) and the
Head-to-Head end-joining(18-bp) was 2.5% ± 0.46% in WT vs. 0.98% in knockouts (n = 3)
(Fig. 8.3 B and C). The low Head-to-Head ligation compared to Head-to-tail can be attributed
to the presence of 3′-phosphates on both the ends.
When the removal of phosphate was compared, there was a disparity observed in the
processing of the overhang and recessed ends even in the WT extracts. This could be
explained by the reduced accessibility of the 3′-phosphate at the recessed end, as the double
strand needs to be unwound to place the phosphate group in the catalytic site (Coquelle et
al., 2011). This unwinding being an energy-requiring process, could have limited the
phosphatase activity at the recessed end. However, retention of a substantial amount of 3′phosphate at the recessed end indicates that PNKP is the prime DNA 3′-phosphatase at the
recessed 3′- DNA ends. Adding back PNKP (100 ng) to knockout extracts resulted in a wildtype phenotype for phosphate removal from the overhang substrate. These observations
suggest that in the absence of PNKP, still there is some processing of the 3′-DNA DSB ends.
And the loss of activity in the knockout extracts can be attributed to loss of PNKP, since the
activity could be restored on adding back recombinant PNKP (Appendix 1, Figure 1A).
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Fig. 8.1: 3′-phosphatase and Nonhomologous end joining (NHEJ) of the 3′-phosphate
overhang and recessed substrates: Incubation of the 3′-phosphate substrates in the
extracts results in the removal of 3′-phosphate producing a 3′-hydroxyl end which was
compatible for end joining. For the partially complementary overhang substrates there will be
a fill-in reaction (blue) before end joining, and on treatment with BstX1 and Taqα1, there will
be the release of 42-nt and 24-nt, Head-to-Tail, and Head-to-Head end joining products,
respectively(A) and a 36-nt and 18-nt, Head-to-Tail and Head-to-Head end joining products
respectively, for the recessed substrate (B).
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Fig. 8.2: Repair of the double strand breaks of DNA with 3′- phosphate overhang by
HCT116 WT and PNKP knockout extracts: Internally 32P -labeled DSB substrate with
3′-partially complementary overhang were incubated in WT and PNKP knockout extracts
for different times mentioned. The samples were later proteolyzed and treated with TaqαI
and BstxI, which were then run on a 20% polyacrylamide gel and exposed to a
phosphoimager screen. The products of processing were visualized on a Typhoon
scanner and quantified using ImageQuant 5.1. A. 3′- phosphate ends are converted into
3′- hydroxyl ends in the extracts, some of which are either Head-to-Tail or Head-to-Head
end joined, running parallel to the markers (M) of the predicted size and sequence.
Because of the negative charge, the unjoined fragment with the 3′-phosphate end runs
faster than the one with 3′-hydroxyl end. Plots display the percentage of phosphate
removal (B), and percentage of end-joining of the Head-to-Tail – 42-nt (C) and Head-toHead - 24 end joining (D) in WT and PNKP knockout extracts ( * -- p < 0.05, ** -- p <
0.005; Student t-test) ( n = 4)
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Fig. 8.3: Processing of the substrate with a recessed 3′-phosphate end at the DSB
by HCT116 WT and PNKP knockout extracts: 32P-labeled 3′-phosphate DSB recessed
end substrates are incubated as indicated and processed similarly to overhang substrates
and run on a gel (A). Plots show the increase in percentage of phosphate removal (B)
and end-joining of the Head-to-Tail – 36-nt (C) and Head-to-Head – 18-nt (D), in WT and
PNKP knockout extracts, as a measure with time. (** -- p < 0.005; Student t-test) (n = 3)
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8.2 Processing of the 3′-tyrosyl substrates in PNKP knockout extracts:
PNKP is also shown to function as a processor of the intermediate 3′-phosphate DNA
ends formed during processing of other complex lesions. For example, chemotherapeutic
drugs such as camptothecin inhibit the re-ligation function of topoisomerase I enzyme, by
inducing the formation of DNA-TOP1 protein covalent complexes at the 3′ end of the DNA
(Plo et al., 2003). These complexes are further processed by peptidases to leave a shorter
peptide linked via a tyrosine residue to the DNA 3′-end forming a covalent
phosphoenzyme intermediate (Gottlin, Rudolph, Zhao, Matthews, & Dixon, 1998). This
DNA-protein complex is resolved by TDP1 enzyme leaving a 3′-phosphate (Interthal et
al., 2005). The removal of this 3′-phosphate is dependent on the enzyme PNKP (T. Zhou
et al., 2009). Hence, to evaluate the processing the DNA-TOP1 complexes in the absence
of PNKP, a DNA 3′-tyrosyl substrate which mimicks the ligand acted upon by TDP1 was
constructed.
Similar to the above experiments, the 3′-phosphotyrosyl substrate was incubated
with WT and PNKP knockout extracts. While in the WT extracts, 3′-phosphotyrosyl ends
were directly converted into 3′-hydroxyl with no detectable intermediates (Fig. 8.4 A lanes
2-7), accumulation of 3′-phosphate was observed in the knockout extracts (Fig. 8.4 A
lanes 7-12). This observation reiterates the requirement of PNKP for the removal of 3′phosphate from the TDP1-processed ends and that loss of PNKP in the knockouts has
prevented its conversion to 3′-hydroxyl and not compensated by any other 3′ phosphatase
for its loss, at least in a part of them. The disappearance of the 3′-phosphotyrosyl is
similarly incomplete in both WT and the knockouts likely due to the extracts containing
insufficient TDP1 to process all the substrate (Fig. 8.4).
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Fig. 8.4: 3′-phosphotyrosyl end processing at the DSB: DNA DSB substrate
mimicking that of the substrate acted upon the TDP1 enzyme was designed by ligating a
radio-labeled oligo with 3′-phosphotyrosyl end at the overhang. This substrate was
incubated in the extracts for different times, processed as in Fig. 8.2, run on a gel and
imaged (A), and the percentage of products formed after processing were plotted
separately for HCT116 WT (upper panel) and PNKP knockout (lower) extracts (B) (n =
2). Accumulation of 3′-phosphate band was visualized in PNKP knockout extracts only.
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8.3 Role of other known 3′-phosphatases in the processing the DNA double-strand
breaks:
PNKP is the sole 3ʹ-phosphatase known to be involved in the repair of DSB’s by
nonhomologous end joining. However, our studies using PNKP knockout extracts have
demonstrated a residual 3′-phosphatase activity at the DSB’s. There is an other enzyme,
APE1, with a weak 3ʹ-phosphatase activity at the SSB’s in the context of BER (Chen,
Herman, & Demple, 1991). Its role in the repair of DSB end-joining is yet to be elucidated.
Aprataxin is another enzyme with limited evidence of 3′-phosphatase activity at the SSB’s,
recessed DSB’s, nicked or gapped DNA (Takahashi et al., 2007). Since these two
enzymes act preferably at the SSB’s, it was hypothesized that end-joining of the
complementary strand at the DSB leaves an SSB with the 3′-phosphate, mimiking a nick,
which can be further processed by either APE-1 or Aprataxin.
To determine whether the ligation of opposite strand is promoting the repair of
the 3′-phosphate end, ligation of the complementary strand was prevented. Since the
ligation of 3′-ACG overhangs requires a fill-in by dTTP in both the strands (as shown in
Fig. 8.1 A), substitution of ddTTP in place of dTTP was attempted to allow the fill-in
reaction but prohibit the ligation. If the ligation of complementary strand instigates the
repair of 3′-phosphate end at the SSB created, blocking this ligation should limit the fill-in
reaction. However, when the reactions were carried out with ddTTP in the reaction, similar
processing (3′-phosphate to 3′-hydroxyl) resulting in equal fill-in at the 3′- 14-nt unjoined
end WT 2.73% vs PNKP -/- 2.9%, to produce 15-nt (one base extended), was observed
after 6 hr of incubation (Fig. 8.4). This observation rules out the role of complementary
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strand ligation in promoting the processing of the 3′-phosphate end at the DSB in PNKP
knockout extracts and thus rules out the role of APE1 and Aprataxin in DSB repair, atleast
at the 3′-phosphate end.
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Fig. 8.5: Role of other 3′-phosphatases in the processing DNA double-strand
breaks: HCT116 WT and PNKP knockout extracts were incubated with the 3′-overhang
substrate in the presence of ddTTP (lane 2 and 4), to block the end-joining of both the
strands after fill-in to eliminate the role of complementary strand ligation in processing the
3′-phosphate end at the DSB’s. A fill-in reaction produces a band corresponding to one
nucleotide higher (15) than the unjoined fragment as a result of blocking the end-joining.
As expected, we could block the end joining in lane 2 and 4, however there was a
prominent a nucleotide fill-in at the unjoined ends, suggesting the removal of 3′-phosphate
even in PNKP knockout extracts (lane 2).
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8.4 Identifying the presence of a non-conventional DNA 5′-kinase in the mammalian
cells:
PNKP is the only known DNA 5′-kinase in the mammalian cell. Evidence of DNA
3′-phosphatase activity in the PNKP knockout extracts brings into question the knockout
status of the cells. To verify if this activity is due to residual activity or perhaps another
isoform of PNKP, we resorted to check the kinase activity on a 5′-OH substrate in these
extracts.
Initially, an indirect phosphorylation assay was done with internally labeled 3′phosphate overhang substrate treated with CIP to create a recessed 5′-hydroxyl ended
substrate with a 3′-hydroxyl ends, in PNKP knockout extracts. For the DNA DSB end
joining, the 5′-hydroxyl must be converted to a 5′-phosphate, and the only known
converter is PNKP enzyme. However, some end-joining was observed for the substrates
with the 5′-hydroxyl end suggesting that there was phosphorylation of the 5′-hydroxyl end
in the absence of PNKP (Fig. 8.6 A lane 5). There was enjoining seen with the 3′-hydroxyl
and 5′-phosphate ended (normal) DSB substrates (Fig. 8.6 A lane 7), as well as in 3′phosphate and 5′-phosphate ended DSB substrates (Fig. 8.6 A lane 3), which was similar
to the observation made in Fig. 8.5. However addition of ddTTP abolished the ligation for
all the substrates, indirectly suffesting a fill-in occuring at all the substrates (lane 2,4 and
6).
One possible reason for this observation can be the 5′-hydroxyl strand
displacement occurring after the 3′-end extension by polymerase δ/ε, and removal of the
5′-hydroxyl flap by FEN-1, simulating the long patch BER (Dobson & Allinson, 2006). For
the extension of the strand to occurs, there must be a fill-in by dTTP follwed by dCTP and
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dGTP in line. Hence to explore the possibility of strand displacement, experiments were
done with ddGTP or ddCTP substitution in the reactions. If the strand extension occurs
by incorporating one of these dideoxynucleotides at the 3′ end, a block in the ligation
should be seen along with increased unjoined fragment length. However, neither of these
substitutions resulted in either the ligation block or the extension of the unjoined product
(Fig. 8.6 B). Hence, the end-joining must have occurred due to direct conversion of the
5′-hydroxyl end to a 5′-phosphate end by a DNA 3′-phosphatase enzyme, rather than a
strand displacement followed by endonuclease (FEN-1) mediated trimming of the
displaced strand. These results led us to a second possibility, presence of a nonconventional DNA 5′-kinase.
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Fig. 8.6: A. Compatibility of the 5′- hydroxyl ends for the end joining: Kinase activity
was screened indirectly by assesing the end joining of 3′-hydroxyl and recessed 5′hydroxyl ends (lane 5) as compared to the end-joining of 3′-hydroxyl and recessed 5′phosphate ends (lane 7), and 3′-phosphate and recessed 5′-phosphate ends (lane 3), all
labeled on the 3′ strands, as a control, in HCT116 PNKP knockout extracts
B. Strand displacement in substrates with 5′-OH end for bypassing the blocked
5′end for strand ligation: Substrates with a 3′-hydroxyl end and either a opposite 5′hydroxyl (lane 1,3,6 and 8) or a 5′-phosphate end (lane 2,4,5 and 7), were incubated
separately in WT or knockout extracts in the presence of ddGTP (lane 1,2 5 and 6) or
ddCTP (lane 3,4,7 and 8) instead of the normal counterparts, dGTP and dCTP, which
would fill-in succession to dTTP at the 3′-end to initiate strand displacement of the 5′hydroxyl end. W = HCT116 Wild-type extract, P = HCT116 PNKP knockout extract
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8.5 Evaluation of DNA 5′-kinase activity in the extracts:
PNKP enzyme preferentially dephosphorylates 5′-hydroxyl termini within nicked, gapped
or DSBs with single-stranded 3′ overhanging ends, compared to single-stranded 5′termini or blunt double-stranded (Karimi-Busheri & Weinfeld, 1997). Therefore, in this
assay, instead of a 3′-end-labeled substrate, a 5′-hydroxyl substrate which was internally
labeled on the same strand was tested for the kinase activity in both HCT116 WT and
PNKP knockout extracts. As observed in Fig. 8.7 B, incubation of the substrates in the
extracts for 6 hours converts the 5′-hydroxyl to a 5′-phosphate, in both extracts albeit to a
lesser extent in the knockout extracts. While 34 ± 6.7% of the 5′-hydroxyl ends were
converted in WT extracts (lane 4), only 6.9 ± 1.5% were converted in PNKP knockout
extracts (lane 5). Pure PNKP (30 ng) (lane 2) and T4PNK (5 U) (lane 3), were used as
positive controls. The conversion of 5′-hydroxyl end observed in knockout extracts might
be an indication of the presence of residual PNKP or the another yet un-known DNA 5′kinase, which needs to be explored further.
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Fig. 8.7: Plasmid DNA DSB’s with 5′-hydroxyl end processing: A. Illustration of 5′hydroxyl ends of the DNA DSB substrate constructed by radiolabeling the XmaI cut 5′
ends of pUC19, on either side and ligating an oligomeric duplex with a recessed 5′hydroxyl ends. B. These DSB substrates were treated with pure PNKP (lane 2) and
T4PNK (lane 3) (1hr), WT (lane 4), and PNKP knockout extracts (lane 5) (6 hr) to observe
for the conversion of a 5′-hydroxyl to 5′-phosphate. These processed substrates were cut
with SmaI to be run on a gel after proteolysis. C. The percentage of phosphorylation
observed at the 5′-hydroxyl ends in HCT116 WT (lane 4) and PNKP knockout extracts
(lane 5) were plotted. (* - p < 0.05; Student t-test) (n = 3)
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8.6 Evaluating the 3′-phosphatase function observed in the extracts as a function
of NHEJ:
PNKP enzyme has the propensity to act on both SSB’s and DSB’s in
multiple repair pathways. Studies have shown that ATM and DNA-PKcs mediate
phosphorylation of PNKP at serines 114 and 12 in a damage-dependent manner (Zolner
et al., 2011a). This phosphorylation, although it does not influence the kinetics of PNKP
accumulation, was shown to increase the turnover of PNKP at the DNA damage sites
(Zolner et al., 2011b). It was also shown that the substitution of T4PNK in PNKPimmunodepleted extracts could not restore the end-joining of 5′-hydroxyl substrates
implying the inaccessibility of the NHEJ protein-bound DNA to a non-specific kinase
(Chappell et al., 2002). Moreover, autophosphorylation of DNA-PK complex (Ku+DNAPKcs), is required for the internal translocation of the complex at the DSB to provide
access to other processing factors to repair/restore the ends for ligation.
This access to to the DSB ends can be blocked by a DNA-PK inhibitor, which
will block the autophosphorylation and thus opening up of the DNA-PK complex. In the
previous experiments done in the lab with TDP1 protein to prove its role as a NHEJ factor,
a DNA-PK inhibitor, NU7441, was used to block the access of the 3′-phosphoglycolate
overhanging ends at the DSB’s to TDP1 enzyme which processes its removal (T. Zhou
et al., 2009). To assess whether the observed 3′-phosphatase activity at the DSBs in the
PNKP knockout extracts is a function of NHEJ, NU7441 was used in the reactions.
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Both the HCT116 WT and PNKP knockout extracts were pre-incubated with
NU7441 for 10 minutes before the addition of the 3′-phosphate substrate. Significant
inhibition of the phosphatase activity (Fig. 8.8), WT by 49 ± 15.58% (lane 4) and PNKP/- by 85 ± 4.8% (lane 8) at 1 μM concentration and by 68 ± 8.1% (WT) (lane 5) and 89 ±
3.78% (PNKP-/-) (lane 9) at 10 μM concentration was seen for the overhang substrate.
There was a likewise significant reduction in the removal of the recessed 3′-phosphate
with 1 μM NU7441 inhibiting the phosphate removal by 62 ± 1.8% in WT (lane 4) and by
81 ± 0.5% in PNKP-/- extracts (lane 8), while addition of 10 μM NU7441 reduced the
removal by 78 ± 2.1% in WT (lane 5) and by 87 ± 0.78% (lane 9) in PNKP-/- extracts.
By comparison, there was a significant decrease in the recessed end
processing relative to overhang processing in the presence of NU7441 in WT extracts as
seen in the plots of overhang ends and recessed ends (Fig. 8.8), signifying the major role
played by PNKP in processing the recessed DNA 3′-phosphate ends, which was shown
by a significant reduction in processing of these ends in PNKP knockout extracts (Fig.
8.3). Furthermore, a significant decrease in processing of the ends, even in knockout
extracts, suggests that the repair factor is depending on DNA-PK function for processing
the ends and hence is a part of NHEJ.
8.7 Accessibility of the 3′-phosphate ends to tissue non-specific alkaline
phosphatase enzyme (CIP):
To reaffirm that the unknown DNA 3′-phosphatase in the cell is a part of NHEJ,
after 10 min of preincubation of extracts with NU7441, followed by recessed 3′-phosphate
substrate incubation for 10 min, 5 units of CIP (a DNA 3′ and 5′-phosphatase) was added
to some reactions. CIP was added to the extracts after preincubation with the inhibitor in
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order to prevent it robust phosphatase activity on the ends even before the formation of
DNA-PK complex.
As evident from Fig. 8.9, in the presence of PNKP in the wild-type extracts, 85%
of the 3′-phosphate ends were processed (lane 1), with a reduction in the removal of 3′phosphate to 39.6% in PNKP knockout extract (lane 2). Addition of CIP did not enhance
the phosphate removal in WT extracts (lane 3), while it enhanced the removal in the PNKP
knockout extracts to 74% (lane 4). 10 μM NU7441, on the other hand could suppress the
phosphatase activity in both WT and PNKP knockout extracts to 31% and 7.4%,
respectively (lane 5 and 6).
However, 10 μM NU7441 does not block the 3′-phosphatase activity of CIP,
79% (vs. 85% no drug) in WT (lane 7) and 70% (vs. 74%) in PNKP knockout extract (lane
8), suggesting that DNA-PK inhibition is capable of blocking only the activity only if it is a
part of NHEJ, but not the non-specific phosphatase enzyme’s activity. While, PNKP and
the other 3′-phosphatase enzyme in the PNKP knockout extracts depend on the
phosphorylation by DNA-PK for the activity at the DSB, CIP can funtion independantly of
the same, suggesting that the alternative enzyme in the knockout extracts is not a nonspecific but a NHEJ factor.
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Fig. 8.8: 3′-phosphatase activity as a function of NHEJ: DNA-PKcs inhibitor, NU7441
was used to block the access of the DSB’s by the enzymes that processes the 3′phosphate ends as a part of NHEJ. NU7441 at concentrations 1 μM and 10 μM (lane 4,8,
and lane 5,9, respectively) was added to both HCT116 WT and PNKP knockout extracts
to test for the inhibition of processing of overhangs (upper panel) and recessed ends
(lower panel), with 3′-phosphates at the DSB’s. The observed level of phosphatase
activity in the extracts was plotted as a percentage of phosphate removal at the mentioned
concentrations of the NU7441 along with controls. Inhibition of activity was evident at both
drug concentrations (lane 4,8, and lane 5,9) Statistical significance: * - WT VS. NU7441
treated WT, $ - PNKP-/- VS. NU7441 treated PNKP -/- (* , $ - p<0.05; ** ,$$ - p< 0.005;
*** ,$$$ - p<0.0005 - One way ANOVA- Dunnett test ) (n = 3) ( C = No drug/DMSO, D =
DMSO).
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Fig. 8.9: Alkaline phosphatase activity on DNA 3′-phosphate recessed end
substrates: DNA 3′-phosphate recessed end substrates were incubated with HCT 116
WT extracts (bar 1) or PNKP knockout extracts (bar 2), some of which were pretreated
with 10 μM NU7441 10 min (lane 5,6,7 and 8). CIP was added to some extracts after
incubation of the substrate in the NU7441 non-treated (bars 3 and 4) and the treated (bars
7 and 8) extracts after 10 min of the incubation of the substrate. The observed phosphate
removal after 6 hr of incubation after addition of CIP, was plotted as a percentage for
each reaction. The plot reveals the inability of the DNA-PK inhibitor to block the CIP (nonspecific) activity while it is blocking the phosphatase activity in the PNKP knockouts. (W = WildType; P = PNKP-/-; C = CIP; N = NU7441) (n = 1)
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8.8 Sub-cellular localization of 3′phosphatase activity:
DNA phosphate ends can also be dephosphorylated by the tissue non-specific
alkaline phosphatase enzyme which is membrane-bound mostly in the extracellular and
cytoplasmic compartments with minimal expression in the nucleus (Hsiang, Hertzberg,
Hecht, & Liu, 1985). However, this activity has no specificity for either 3′ or 5′ ends. PNKP
is a nuclear enzyme and is found in small quantities in mitochondria. Depletion of nuclear
PNKP with shRNA was shown to deplete mtPNKP (Tahbaz, Subedi, & Weinfeld, 2012).
Experiments performed in whole cell extracts revealed a 3′-phosphatase activity even in
the absence of PNKP.
To compartmentalize the observed 3′-phosphatase activity in the knockout
extracts, nuclear/cytosolic fractionation was made using BioVision kit. Overhang 3′phosphate substrates were incubated for different times as shown in Fig. 8.10 A. Similar
to the whole cell extracts, there was 3′-phosphatase activity (80 ± 0.12%) in the PNKP
knockout nuclear extracts after 120 min incubation (Fig. 8.10 A lane 7). This suggests
that the suspected DNA 3′- phosphatase enzyme acting at the DSB is present in the
nucleus. Also, there was digestion of the DNA seen on incubation of the overhang
substrates for 120 min in both the extracts, suggesting possible exonucleolytic digestion
of the converted 3′ hydroxyl ends. The digestion of the processed ends is probably due
to a lack of protection of these ends which would be present in whole cell extracts.
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Fig. 8.10: Detection of 3′ phosphatase activity in the nuclear extracts: A. Overhang
3′-phosphate substrates were incubated in the HCT116 WT or PNKP-/- extracts for 5, 30
and 120 min, processed and run on the gel. B. Observed removal of phosphate in both
the extracts was plotted as a percentage of time. Phosphatase activity was evident in the
PNKP knockout nuclear extracts (lane 3, 5 and 7). (n = 2)
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8.9 Assessing the role of XRCC4 in DNA kinase and phosphatase activities:
DNA-PK, a core NHEJ factor was shown to influence the DNA 3′-phosphatase
activity in the above experiments. Numerous studies on the role of XRCC4, another core
NHEJ factor, interacting with and influencing the function of PNKP, have revealed
complex interactions (Aceytuno et al., 2017b) (Chappell et al., 2002) (Mani et al., 2010a).
As with the other accessory repair proteins, PNKP also interacts with the scaffold formed
by XLF and XRCC4/LigaseIV complex. PNKP interaction with XRCC4 is by dual modes,
with phosphorylated (pXRCC4) and non-phosphorylated form (XRCC4) (Fig. 6.1 B).
Interacting with XRCC4 or pXRCC4/LigaseIV is shown to increase PNKP turnover at the
5′-hydroxyl ends after phosphorylation, and the lack of XRCC4 has reduce the kinase
activity (Mani et al., 2010b). Phosphatase activity of PNKP was shown to be predominant
over kinase activity (Dobson & Allinson, 2006). Nevertheless, not much work has been
done regarding the effect of XRCC4 on the DNA 3′-phosphatase activity of PNKP.
By adding HCT116 XRCC4 knockout extracts to the DNA 3′-hydroxyl and 5′phosphate substrates, we attempted to define XRCC4’s role in PNKP activity. The
observed activity in these extracts was compared to the activity in HCT116 WT extracts
(lane 1), HCT116 PNKP knockout extracts (lane 2), and to the activity restored after the
addition of pure protein 0.6 µg of XRCC4 (lane 4) or pure 30 ng of PNKP to the XRCC4
knockout extracts. As observed in the Fig. 8.11, the absence of XRCC4 in the extracts
has reduced the phosphatase by 47 ± 6.1% and kinase activity by 40 ± 1.4% as compared
to the wild-type extracts (lane 3). There was no end-joining observed in either the WT or
PNKP knockout extracts since the incubation period was only one hour for 3′-phosphate
substrates and due to incompatible ends in 5′-hydroxyl substrates, incubated for 5 hours.
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Adding back 0.6 μg XRCC4/LigaseIV protein not only enhanced the 5′-kinase (58 ± 10%)
and 3′-phosphatase activities (92 ± 7.4%), but also strongly promoted end-joining for both
the substrates (lane 4). This suggests that even at the physiological concentrations of
PNKP present in the extracts, it requires XRCC4 for the enhancement of the catalytic
activity. Adding 30 ng of pure PNKP, there was an obvious (37 ± 8.3%) increase in the
3′-phosphatase activity (similar to WT) and around 3.8 ± 0.25% increase in the 5′-kinase
activity (still somewhat less than WT) in XRCC4-/- extracts (lane 5). This further proves
that while the added PNKP can act on the available 3′-phosphate ends, XRCC4 is
required to reduce its affinity at the phosphorylated ends, and therefore absence of
XRCC4 in the knockouts attenuates the turnover of the added PNKP, limiting the kinase
activity. End joining of the non-complementary ends of hydroxyl substrates proves the
ability of XRCC4/Ligase IV to promote ligation such ends. And also, since the experiment
with both the substrates is performed in parallel using the same extracts, the difference
in potency of the DNA 3′-phosphatase activity vs. 5′-kinase activity of PNKP is clearly
seen for all the extracts and protein additions. As reported, the phosphatase activity (1 hr
incubation) is predominant over kinase activity (5 hr incubation)..
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Fig. 8.11: XRCC4/LigaseIV enhances PNKP activity: HCT116 XRCC4 knockout cell
extracts were used to assess the DNA 3′-phosphatase (1hr incubation), and 5′-kinase
activities (5 hr incubation), using respective substrates. Recombinant proteins, 0.6 μg of
XRCC4/LigaseIV and 100 ng of PNKP were added to these extracts, separately. A. Gel
images of the products resulting from processing of 3′-phosphate (right panel) and 5′hydroxyl (left panel) substrates B. Percentage of conversions of each substrate ends is
plotted. While the lack of XRCC4 reduced the activities (lane 3), adding back XRCC4 to
the knockout increased the activities, and promoted end joining (lane 4), while the added
PNKP stimulated phosphatase activity only (lane 5). 1. Wild-type, 2. PNKP knockout, 3.
XRCC4 knockout, 4. XRCC4 knockout+recombinant XRCC4, 5. XRCC4 knockout + pure
PNKP. (n = 3)
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8.10 Role of XLF in processing the 3′-phosphate or 5′-hydroxyl ended DNA DSB’s:
Previous studies evaluating the role of XRCC4 in PNKP function have shown
either a non-phosphorylated XRCC4 or an XRCC4/LigIV complex, independent of Thr233 phosphorylation status increases the turnover of PNKP at the 5′-phosphorylated ends
of DNA DSB’s (Mani et al., 2010). XRCC4 interacts with XLF creating a helical filament
of alternating XRCC4 and XLF dimers, thus stabilizing DNA end synapsis (Wu et al.,
2011). XLF is shown to promote the re-adenylation of DNA Ligase IV, thus reactivating
its active site, independent of its interaction with XRCC4 (Roy et al., 2015).
Based on this evidence, an attempt was made to study XLF’s role in phosphatase
and kinase activities in Bustel fibroblast extracts (deficient in XLF). 3′-phosphate DNA
DSB substrates and 5′-hydroxyl DNA DSB substrates were employed to evaluate the
phosphatase and kinase activities respectively. Upon incubation for 6 hr in Bus extracts
with and without complementation of XLF, an increase in the kinase activity by 30.7 ±
3.2% was observed on XLF substitution ( Fig. 8.12 lane 9) with no discernable change in
phosphatase activity on both overhang (lane 2 and 3) and recessed 3′-phosphate
substrates (lane 5 and 6), suggesting a possible influence of XLF in processing the 5′hydroxyl at DSB’s by PNKP, by increasing its turnover similar to XRCC4. End joining of
phosphate substrates has occurred in the presence of XLF (lane 3 and 6), which could
not occur in its absence (lane 2 and 5), reinstating the requirement of XLF for the ligation
of a DSB, especially in extracts. However, owing to the non-complementarity of the ends,
there was no end joining of 5′-hydroxyl substrates.
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Fig. 8.12: Effect of XLF on the phosphatase and kinase activity: Substrates with 3′phosphate (overhang (lane 1,2 and 3) or recessed (lane 4,5 and 6)) or 5′-hydroxyl ends
(lane 7,8 and 9, at the DSB’s were incubated in Bus extract with (lane 3,6,9)/without
XLF(lane 2,5 and 8) for 6 hr, and the phosphatase and kinase activities were assessed
by measuring the conversion of the 3′-phosphate ends to 3′-hydroxyl ends and 5′-hydroxyl
ends to 5′-phosphate ends. B. The observed kinase activity in the presence and absence
of XLF was plotted as percentage. As observed on the gel there was no difference in the
presence and of XLF in phosphatatase activity (lane 2 vs. lane 3 and lane 5 vs. lane 6).
However, kinase activity was stimulated by PNKP (lane 8 vs. lane9). There was promotion
of end joining for both the 3′-phosphate substrates (lanes 3 and 6). (n = 3)
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Results from all the above experiments led to two speculations. One possibility is
that there could be either residual PNKP due to insufficient knockout or the presence of
an isoform of PNKP. Literature reveals that there is another isoform of PNKP which is 40
amino acids shorter at the aminoterminal FHA region where the first 1-50 aminoacids
MGEVEAPGRLWLESPPGGAPPIFLPSDGQALVLGRGPLTQVTDRKCSRTQ
replaced by

are

MQILTPPLQSS (GCID:GC19M049861). However, CRISPR mediated

targetting of Exon3 would knock out both the isoforms. The other possibility is the
presence of alternative DNA 3′-phosphatases and 5′-kinases.
8.11 Detection of PNKP by Western Blot using alternative antibodies:
The only confirmation to this point regarding the knockout status of the HCT116 cells is
the western blot analysis done by using a mouse monoclonal antibody targeting an
epitope of aa 1-140 of PNKP which detects the FHA domain of PNKP. PNKP interacts
with XRCC4 via the FHA domain (pXRCC4) and the catalytic domain (XRCC4) at the
DSBs (Mani et al., 2010b). Lack of detection of the FHA domain leaves a possible
presence of catalytic domain (phosphatase and kinase) which might be responsible for
the observed activity in the extracts.
Western blot experiments were repeated using Rabbit anti-PNKP polyclonal antibody
(full-length epitope) and a mouse anti-PNKP monoclonal antibody which detects Cterminal aa 379-411, for verifying the presence or absence of the catalytic domain of
PNKP (Fig. 8.13 A and B). Surprisingly, there was a band detection with both the
antibodies (Fig. 8.13 lane 5 (left and right panels)). For PNKP knockout in these cells,
CRISPR was targeted Exon 3 (Appendix II), resulting in deletion and rearrangement in
Allele 1 and an in-frame insertion and two site mutation in Allele 2. While the first allele
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targetting should eliminate the expression of the protein, the insertion in the second allele
targetting appeared to allow for expression of a full-length protein. However, the observed
band (lane 5, right panel) appeared slightly lower in the gel than the full-length protein,
which is not consistent with an in-frame insertion. This observation suggests a possible
presence of a truncated PNKP, although its contribution to the activity seen in the
knockout extracts requires further elucidation.
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Fig. 8.13: PNKP detection in the knockout extracts by Western blot: HCT116 WT
and PNKP knockout cytoplasmic and nuclear extracts extracts (50 µg) were resolved on
10% SDS-PAGE. After transfer to 0.45 μm nitrocellulose the blotted bands were
immunodetected with either a rabbit anti-PNKP polyclonal antibody (whole protein
epitope) (A) and mouse anti-PNKP monoclonal antibody (Mab) (aa 379-411 epitope) (B)
and subsequently visualized with peroxidase labeled rabbit anti-rabbit IgG (A) or antimouse IgG (B) antibodies. Band detected in the WT nuclear extracts (lane 4) is migrating
with the recombinant protein (lane 1). There is a band detected in lane 5 (PNKP knockout
nuclear) of both the blots with the band in the right panel running faster than the WT.
GAPDH was used as a loading control. For both the blots, Lane1: Recombinant hPNKP,
Lane 2: HCT116 WT cytoplasmic extract, Lane 3: HCT116 PNKP knockout cytoplasmic
extract, Lane 4: HCT116 WT nuclear extract, Lane 5: HCT116 PNKP knockout nuclear
extract, kD: kilo Dalton – molecular weight of the protein.
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8.12 Dilutional analysis of the detected PNKP:
The appearance of this band was not be predicted by DNA sequencing of the
knockout but could not be attributed to the PNKP isoform which is approximately 4 kD
less than the conventional PNKP. We quantified the band detected in knockout extracts
as a fraction of that detected in wild-type extracts by the mouse Mab.
Starting with 2 mg/ml, priteins contained in increasing dilutions of HCT116 wildtype nuclear extracts were resolved on AnyKD gel along with the 2 mg/ml of PNKP
knockout nuclear extract. The sensitivity of detection of PNKP was increased by using
SuperSignal™ Western Blot Enhancer kit. After transfer to 0.45 μm nitrocellulose
membrane, the blot was incubated with antigen pretreatment solution for 10 min before
blocking, followed by incubation with the mouse Mab (aa 379-411) in the primary antibody
diluent provided in the kit. These blot treatments resulted in a clear enhancement of the
bands with less background. The intensity of the bands detected on the blots was
measured using ImageJ software. As seen in the Fig. 8.14, the band detected in PNKP
knockout extract appeared to be running as a doublet (lane 8). When quantified and
interpolated to the dilutions of the HCT116 WT nuclear extracts on a log scale; it was
found to be approximately 1/13th of the level found in WT nuclear extracts.

115

Recombinant PNKP
1

2

3

4

5

6

7

8

Fig. 8.14: Dilutional analysis of PNKP in the knockout nuclear extracts: Increasing
dilutions of the HCT116 WT nuclear extract (Lanes 2 to 7) along with the PNKP knockout
extract (lane 8) were resolved on AnyKD gel, transferred on to to 0.45 μm nitrocellulose
membrane was treated with SuperSignalTM antigen pretreatment solution for 10 min
before being blocked. The mouse anti-PNKP Mab (aa 379-411), was diluted in the
SuperSignalTM primary antibody diluent for overnight incubation of the blot which was
subsequently visualized with peroxidase labeled anti-mouse IgG. Image J software was
used to quantify the band intensities which were plotted to derive the intensity of the band
detected in the PNKP knoctouts as a fraction of WT intensities. GAPDH was used as a
loading control. The band detected in lane 8 (PNKP knockout) appears to be running like
a doublet and its intensity was approximately 1/13th of the WT undiluted extract. Lane 1:
Recombinant PNKP, Lane 2-7: Increasing dilutions of HCT116 WT nuclear extract, Lane
8: HCT116 PNKP knockout nuclear extract.
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8.13 Western blots on HeLa extracts:
Due to the possibility of the band detected by PNKP antibody in the HCT116 PNKP
knockouts to be functional PNKP, we have also obtained HeLa PNKP Knockout cells
from Dr. Weinfeld along with CRISPR controls to repeat the phosphatase and kinase
assays. The gene sequencing data (Appendix II) and the western blot provided by his
laboratory suggested a clean knockout of all the three allelles of PNKP. Western blot
analysis of the cytoplasmic and nuclear extracts of the cells was done using the rabbit
anti-PNKP polyclonal antibody (full-length epitope) and a mouse anti-PNKP Mab (379411).
As shown in the Fig. 8.15, after probing with peroxidase tagged specific secondary
antibodies, there was a faint band (lane 5) detected with the polyclonal antibody after 5
min exposure, without any band detection mouse monoclonal antibody (lane 5) even after
30 min exposure to X-ray screen. This lack of band detection suggested a clean knockout
of PNKP in the HeLa extracts. These extracts were used to corroborate the findings
obtained for processing the 3′-phosphate and 5′-hydroxyl ends in HCT116 PNKP
knockout extracts.
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Fig. 8.15: PNKP knockout status verification on Western blot: HeLa WT and PNKP
knockout extracts were resolved on 10% SDS-PAGE and transferred on to to 0.45 μm
nitrocellulose membrane, which was treated with mouse anti-PNKP Mab targeting aa 379411 (top panel), rabbit anti-PNKP antibody (full-length) (middle panel) and detected with
peroxidase labeled specific secondary IgG. While the lane 5 in the top panel was clean
even after 30 min exposure, a faint band was detected anti-rabbit secondary (lane 5) after
5 min exposure to X-ray. GAPDH control was detected with Alexa Flour 680 labeled antimouse IgG (bottom panel).
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8.14 Experiments in HeLa Extracts:
To substantiate the findings made in the HCT116 knockout extracts and to rule
out that the band detected in the HCT116 PNKP knockout extracts (Fig. 8.13 lane 5 (right
panel) and Fig. 8.14 lane 7) is contributing to the activity seen in those extracts, HeLa
PNKP knockout extracts which were confirmed to lack any PNKP by the same antibodies
that detected its presence in HCT116 knockouts, were used to study the DNA 3′phosphatase and 5′-kinase activities. As with the above experiments in HCT116 extracts,
the 3′ –phosphate and 5′-hydroxyl substrates were incubated in the wild-type and PNKP
knockout whole cell extracts for various times.
These experiments have revealed similar processing of the 3′-phosphate
recessed end, WT- 88.27 ± 1.68% vs. PNKP-/- - 33.0 ± 1.85%, with the retention of some
3′-phosphate even in wild-type extracts (Fig. 8.17), as in HCT116 extracts (Fig. 8.3).
Moreover, 53.3 ± 11.2% of 3′-phosphate was removed from the 3′ overhang substrates
in the HeLa PNKP knockout extracts with complete removal in the WT (Fig. 8.16). Also,
DNA-PK inhibitor NU7441 blocked the removal of 3′-phosphate in both WT and PNKP
knockout extracts, for either substrate. 1 μM NU7441 reduced the phosphate removal
from the overhang substrate by 49% in WT and 56% PNKP-/- extracts from the overhang
substrate (Fig. 8.16 lane 3 and 6), while 10 μM reduced 68% in WT and 57.1% in PNKP/- extracts (Fig. 8.16 lane 4 and 7).
On the other hand, 1 μM NU7441 reduced the phosphate removal by 48.6 ±
2.4% in WT and 35 ± 0.8% in PNKP -/- (Fig. 8.17 lane 4 and 8), and 10 μM reduced it by

119

68 ± 1.71% in WT and 38.4 ± 0.44% in PNKP-/-, from the recessed substrate (Fig. 8.17
lane 5 and 9).Total Inhibition in the HeLa WT extracts was lower than HCT116 extracts
due to the increased activity of PNKP owing to the presence of more amount of PNKP in
the extracts as detected in the Western blot analysis of 50 μg of WT extracts.
In addition, when assesed for DNA 5′-kinase activity in HeLa PNKP knockout
extracts, 9.6 ± 1.91% (Fig. 8.18 lane 5) of the 5′ phosphate ends were formed compared
to 44.5 ± 1.1% (lane 4) in the wild-type extracts after 4 hr incubation. DNA 3′-phosphatase
activity was found in the nuclear fraction of both the WT and knockout extracts with the
total removal and digestion of the substrate in WT extract and retention of 78 ± 0.34%
(Fig. 8.19 lane 7) of the 3′-phosphate in the knockout extracts with little obvious digestion
of the substrate.
Since the above results of phosphatase assay (Fig. 8.16 and 8.17) and of
kinase assay (Fig. 8.18) have shown processing very similar to that of processing
occuring in HCT116 PNKP knockout extracts, it is likely though not certain that 3′phosphatase and 5′-kinase activities in the HCT116 PNKP knockout extracts is also due
to alternative 3′-phosphatases and 5′-kinases, rather than to the minute amount of the
truncated PNKP detected in that extract by Western blot. DNA-PK inhibition (Fig. 8.16
and 8.17 B,D), suggest the phosphatase activity found in the knockouts to be a part of
NHEJ similar to HCT116 knockout extracts (Fig. 8.8). However, there is a wide disparity
detected in the 3′-phosphatase activity between HCT116 and HeLa nuclear extracts.
While 80 ± 0.12% (Fig. 8.10) 3′-phosphate ends were processed in HCT116 extracts, only
22 ± 0.34% (Fig. 8.19) 3′-phosphate ends were processed in HeLa. On the whole, these
observations suggest the presence of alternatives to the enzyme PNKP.
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Fig. 8.16: Effect of PNKP knockout on processing the 3′-phosphate ends of
overhangs at the DSB’s and susceptibility to DNA-PKcs inhibition: A. Internally
radio-labeled 3′-phosphate ended overhang substrate was incubated in HeLa WT, and
PNKP-/-/- extracts for different times as indicated, was proteolyzed and cut with BstXI and
AvaI and run on a gel. B and C. Percentage of phosphate removal as a function of time
was measured and plotted for both the extracts. For samples with DNA-PKcs inhibitor
NU7441 (lane 3,4,6 and 7), the extracts were incubated with NU7441 for 10 min before
the addition of substrate, then incubated for additional 4 hours. Released bands are one
base longer than those for TaqαI cut DNA. There was a reduction in total processing in
the knockouts (lane 17) compared to WT (lane 16). Presence of NU7441 inhibited the 3′-
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phosphatase activity, including in the knockouts (lane 3,4,6 and 7) (C = No DMSO/Drug,
D = DMSO control) (B. n = 3, C. n = 1)

1234 5 67 89
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Fig. 8.17: Effect of PNKP knockout on processing the 3′-phosphate ends of
recessed end at the DSB’s and susceptibility to DNA-PKcs inhibition: A) Internally
radio-labeled 3′ strand with a 3′-phosphate at the recessed end was incubated in HeLa
WT and PNKP-/-/- extracts for different times as indicated, then were processed similar
to overhang substrates and run on a gel. B. Percentage of phosphate removal as a
function of time was measured and plotted for both the extracts. C. For samples with
DNA-PKcs inhibitor (NU7441), the extracts were incubated with NU7441 (lane 4,5,8 and
9) for 10 min before the addition of substrate, which were then incubated for 4 hours and
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the observations were plotted (D). 3′-phosphate processing was incomplete in knockout
extracts (A. lane 9) compared to the wild-type extracts (A. lane 8). NU7441 inhibited
the3′-phosphatase activity in both the extracts (B. lane 4,5,8 and 9). (C = No DMSO/Drug,
D = DMSO control) (n = 2)
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Fig. 8.18: Effect of PNKP knockout on the kinase activity on 5′-hydroxyl substrates:
Substrates with 5′-hydroxyl substrates labeled on the 5′-strand, were incubated with the
pure PNKP (lane 2) and T4PNK (lane 3) for 1hr , HeLa WT (lane 4) and PNKP-/- (lane
5) extracts for 4 hr, proteolyzed, cut with SmaI and run on a gel. A. Gel picture of the
migrating 5′-OH (above) and 5′-PO4 (below) at all treatments. B. The formation of 5′phosphate was measured as a percentage and plotted for the extracts (lane 4 and 5).
(** - p < 0.005; Student t test ) (n = 3)
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Fig. 8.19: 3′-phosphatase activity in HeLa Nuclear extracts: 3′-phosphate overhang
substrate was incubated in the WT (lane 2,3 and 4) and PNKP knockout (lane 5,6 and
7) nuclear extracts made by nuclear/cytoplasmic fractionation, for the indicated times,
proteolyzed, cut with AvaI and was run on a 20% gel (A). Observed phosphate removal
was plotted as a percentage for both WT and PNKP knockout extracts. Reduction of the
removal of 3′-phosphate from the knockout extracts can be clearly depicted from the gel
(lane 7) compared to WT (lane 4) and from the plot (B).
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8.15 Pharmacological inhibition of DNA 3′-phosphatase activity:
To test whether the 3′-phosphatase activity was attributable to the suspected
residual PNKP protein detected by western blot in PNKP knockout extracts, PNKP
inhibitor, ST042146, was used to pharmacologically inhibit the phosphatase activity of the
PNKP, and thereby reveal the activity of any other DNA 3′-phosphatase acting in the
context of NHEJ.
To evaluate the PNKP inhibition, 100 ng of recombinant PNKP was preincubated for
10 min with different concentrations ST042164 dissolved in DMSO, before adding the 3′phosphate overhang substrate. As seen from Fig. 8.20, after 1 hr of incubation DMSO
appears to significantly inhibit the phosphatase activity (lane 3), increasing the fraction of
3′-phosphate remaining from essentially zero to 33% . However, ST042164 was seen to
increasingly inhibit the activity of the enzyme with increasing concentrations (lane 4-6).
50 μM concentration of the drug was shown to inhibit most (3.9%, lane 6) of the 3′phosphatase activity.
Since we observed no inhibition on DNA 3′-phosphatase in the whole cell
extracts even at higher concentrations (200 μM) of ST042164, we tried to simulate the
conditions in which the drug was shown to be effective during its characterization. The
extracts were diluted (1:125) in a storage buffer similar to the one in which PNKP was
stored and the phosphatase buffer was used in the reaction (as described in Methods
7.10), to assess inhibition of 3′-phosphatase activity in the extracts. After 10 min of
preincubation in the extracts, the 3′-phosphate overhang substrate was added to the
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diluted extracts. At concentrations of 20μM and 50μM of ST042164, there was a 48 ±
1.1% and 56 ± 0.72% of reduction in the DNA 3′-phosphatase activity in the diluted
HCT116 WT extracts after 1 hr incubation (Fig. 8.21 lane 4 and 5), but only about 12.5 ±
2.3% reduction of the activity in the diluted HCT116 PNKP knockout extracts at both
concentrations of the drug even after 3 hr incubation (Fig. 8.21 lane 8 and 9). The inability
of the drug to curb the phosphatase activity in the PNKP knockout extracts propones the
activity of another factor with a similar function to PNKP, at least the 3′ phosphatase. Also,
the presence of the drug inhibited the digestion of the substrate in both extracts,
suggesting a lower conversion to 3′-hydroxyl ends, which are better substrates for the
exonucleases. Experiments repeated with diluted HeLa extracts gave similar results with
the drug highly inhibiting the phosphatase activity in WT extracts but not in the PNKP
knockout extracts.
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Fig. 8.20: ST042164-mediated inhibition of DNA 3′-phosphatase activity of
recombinant PNKP: A. Recombinant PNKP (100 ng) was pretreated in the reactions
with either DMSO (lane 3) or different concentrations of the inhibitor ST042164 (lanes 46), before adding the 3′-phosphate overhang substrate to the reactions. After adding the
substrate, these reactions were further incubated for 1 hr. The reactions were
deproteinized, then DNA was cut with AvaI and the products were run on a gel. B.
Percentage of phosphate removal by PNKP was plotted for different reactions. As seen
from the gel and the plot there was nearly complete inhibition of phosphate removal from
the 3′-phosphate ends by ST042164. (C = No drug/DMSO control, D = DMSO control) (n
= 1)
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Fig. 8.21: ST042164-mediated inhibition of DNA 3′ phosphatase activity: A. Diluted
HCT116 WT and PNKP knockout extracts were incubated with the defined concentrations
of the heated drug for 10 min before addition of a 3′-phosphate overhang substrate. After
proteolysis and AvaI treatments, products released were run on the gel. B. Image of the
plot displays the percentage of phosphate removal in both the extracts in the absence
and presence of ST042164 at the indicated concentrations. Reduction in phosphate
removal was seen at both the concentrations of the drug (A. lane 4,5,8 and 9) for both
the extracts with a much smaller inhibition in PNKP knockout extracts (A. lane 8 and 9)
(C = No DMSO/Drug, D = DMSO control) (n = 2).
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IX Discussion

DNA is one of the four major biomolecules in a cell, encoding genetic
information which is faithfully carried across generations. Though initially thought to be a
stable molecule by the discoverers, Watson and Crick, many have since shown that DNA
is readily susceptible to chemical modifications by external and internal stress factors.
These alterations if not repaired efficiently can result in numerous unwanted
consequences such as aging (Hoeijmakers, 2009), cancer (Loeb & Harris, 2008) (PazElizur et al., 2008) and neurological development disorders (McKinnon, 2009). A battery
of robust DNA repair pathways have evolved to counter cytotoxic and mutational damage
in a cell, functioning in a lesion-specific manner to ensure genomic stability.
Many studies have shown that defects in the DNA damage response and
repair pathways are a double-edged sword, either leading to the development of tumors
or rendering them resistant to cancer chemotherapy and radiotherapy whose primary goal
is to kill cancer cells mostly by inducing DNA damage (Hosoya & Miyagawa, 2014). Thus,
DNA response/repair factors have become potential therapeutic targets in the the recent
years (Hosoya & Miyagawa, 2014) (Zhu, Hu, Hu, & Liu, 2009) (Bhattacharjee & Nandi,
2017). In every repair pathway, there are a plethora of enzymatic activities such as
nucleases,

helicases,

polymerases,

topoisomerases,
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recombinases,

ligases,

glycosylases, demethylases, kinases, and phosphatases modifying the damaged DNA in
a regulated fashion (Ciccia & Elledge, 2010a).
One such enzyme, Polynucleotide kinase phosphatase (PNKP), a bifunctional
enzyme with DNA 5′-kinase and 3′-phosphatase activities, is required to modify ends of a
DNA break before ligation. Occurrence of 3′- phosphate termini at the DNA breaks is
common and can arise from a number of sources including reactive oxygen species,
Tdp1 processing of stalled topoisomerase I complexes generated by the drug
camptothecin (Yang et al., 1996) and as intermediates in a sub-pathway of base excision
repair of oxidative base damage (Wiederhold et al., 2004). Nonetheless, occurrence of
the 5′-hydroxyl termini is rare, being produced due to strand scission, e.g. ionising
radiation (Coquerelle, Bopp, Kessler, & Hagen, 1973) camptothecin treatment, (Hsiang,
Hertzberg, Hecht, & Liu, 1985) or by DNase II action. PNKP plays a crucial role in the
repair of the complex double strand and single strand breaks induced by oxidative factors
or repair-intermediates produced during their resolution. Like any other DNA repair factor,
PNKP mutations have been identified as an etiology for neurological disorders
(Dumitrache & McKinnon, 2017). Moreover, its involvement in various repair pathways
made it an attractive target for chemotherapy of cancer (Allinson, 2010).
There is a considerable evidence regarding the participation of PNKP enzyme in
NHEJ, one of the two major DSBR pathways (Chappell, Hanakahi, Karimi-Busheri,
Weinfeld, & West, 2002b) (Chappell et al., 2002b), with accumulation of double-strand
breaks in mouse models of PNKP deficiency (Shimada, Dumitrache, Russell, &
McKinnon, 2015). However, no other factor has yet been identified to take over the role
of PNKP in the repair of the 3′-phosphate and 5′-hydroxyl lesions at DSBs. An attempt
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was made in our lab to screen for any such factor either by knocking down PNKP in
HCT116 or treatment with a PNKP inhibitor, A12B4C3. None of these approaches were
able to produce a distinction in the repair of 3′-phosphates DNA ends resulting from NCS
treatment, as evidenced by screening the formation of 3′-hydroxyl ends by Ligationmediated PCR (LMPCR). Therefore, for our current study, we employed CRISPR
mediated PNKP knockout cells to ensure a complete loss of PNKP activity. Initially,
HCT116 cells with PNKP knockout were acquired from Dr. Weinfeld’s lab, and the
knockout status was verified with the in-house mouse anti-PNKP monoclonal antibody
raised against the N-terminal aa 1-140 peptide of the human PNKP enzyme. Survival and
53-bp1 repair foci (marker for NHEJ) assays done after NCS treatment of wild-type and
PNKP knockout cells. There was a reduced survival and persistence of the repair foci in
knockout cells.
Further, we proceeded to evaluate the specific enzymatic activities of PNKP, i.e.,
DNA 3′-phosphatase and 5′-kinase functions, in the absence of PNKP. To determine the
same, specific radiolabeled DSB substrates were constructed with either a 3′-phosphate,
3′-phosphotyrosine or 5′-hydroxyl ends and cell-free whole cell extracts of HCT116 WT
and PNKP knockout cells to process these substrates. Substrates with a 3′-phosphate
end have either a partial complementary overhang or a complementary recessed end.
Even in the absence of PNKP, removal of ~80% of the 3′-phosphate was seen for the
overhang substrates. However, there was a severe limitation (~24%) in the processing of
the recessed ends. Electrophoretic mobility shift assays done to characterize the DNA
substrates have shown recessed end substrate to be a better binder than the overhangs
(Havali-Shahriari, Weinfeld, & Glover, 2017). Surprisingly our experiments have shown
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incomplete removal of 3′-phosphate from the recessed ends (Fig. 8.3). Structural studies
of PNKP have demonstrated a narrow and deep active site cleft which could
accommodate single but not double-stranded substrates (Coquelle, Havali-Shahriari,
Bernstein, Green, & Glover, 2011b). The minimal substrate required for the catalysis in
the phosphatase domain is a single-stranded three-nucleotide 3′-phosphorylated DNA
(Bernstein et al., 2005). Destabilization of the double strand must occur to place the 3′phosphate end of one strand in the narrow 3′-phosphatase cleft. Therefore, it can be
hypothesized that the 3′-phosphate from the 3′-end with a 3 base overhang was easily
accessible and hence the removal was rapid and complete, while the destabilization
energy spent in accessing the 3′-phosphate at the recessed end, likely limited the catalytic
activity on the substrate. Further, evaluation of processing of 3′-phosphotyrosyl
substrates in the extracts revealed an accumulation of 3′-phosphates in the knockout
extracts but not in the WT extracts, suggesting a deficiency of PNKP in the extracts.
APE1, an important constituent enzyme of BER is known to resolve various 3′ end
blocks at SSB’s, including 3′–phosphatases (M. Li, Wilson, & III, 2014). However, the 3′PG and 3′-phosphate removal activities of APE1 are ∼70-fold lower than the
endonuclease activity and it acts efficiently only at the recessed end of a double-strand
break, at least for 3′-phosphoglycolates. It can be hypothesized that in the absence of
PNKP, APE1 can take over the 3′-phosphatase function. Another enzyme Aprataxin is
shown to repair DNA single-strand breaks with damaged 3′-phosphate and 3′phosphoglycolate ends (Takahashi et al., 2007). On the other hand, Aprataxin also has
an FHA domain similar to PNKP and interacts with CK2- phosphorylated XRRC4 similarly
to PNKP, in a mutually exclusive manner (Ahel et al., 2006b). Hence, there can be a
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competition between the two proteins in binding to XRCC4. One possible deciding factor
for the interaction is the DNA substrate specificity. However, the primary function of
Aprataxin is to resolve the adenylated 5ʹ- ends of the DNA due to abortive ligation
mediated by Ligase IV. In wild-type extracts, spontaneous activity of PNKP renders the
ends ligatable almost immediately. Nonetheless, lack of PNKP in the knockout extracts
results in the persistence of the 3′-phosphate at breaks, and if accompanied by 5ʹphosphate at the other end, there will be accumulation of 5ʹ-AMP (adenyl) ends due to
abortive ligation. This accumulation along with the lack of the competitive PNKP might
enhance the amount of Aprataxin binding with pXRCC4 at the non-ligated break. This
increased presence of Aprataxin at the break might result in the dephosphorylation of the
3′-ends. However, APE1 and Aprataxin were shown to possess 3′-phosphatase activity
at the SSB’s. Experiments done to block the ligation of the opposite strand which can
create a suitable substrate for APE1 and Aprataxin did not inhibit the repair of the
damaged strands, limiting the evidence of their involvement in the repair of DSBs in PNKP
knockout extracts. Recombinant protein assays with APE1 and Aprataxin, with and
without core NHEJ recombinant proteins, using DSB substrates might reveal the function
of these proteins.
All the above 3′-phosphate substrates had a 5′-phosphate end enabling the
end joining at the 3′-hydroxyl ends. Though the presence of a 5′-hydroxyl end is not
necessary for the extension of the DNA strand at 3′ end, ligation of the stand does. Any
block at the 5′ end can be successfully overcome by strand displacement. Our substrates
possessing 5′-OH ends, labeled on the 3′-end displayed end joining in the PNKP knockout
extracts without any evidence of strand displacement (Fig. 8.6 B). This finding was an
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indirect measure of the kinase function in the PNKP knockout extracts. Direct evidence
of the kinase activity in the knockout extracts was obtained by incubating 5′-OH substrates
labeled on the same strand. The observed total kinase activity in the extracts was less
than the phosphatase activity (Fig. 8.6).
Before deducing the presence of other repair factors that might function similarly
to PNKP, western blot experiments with antibodies that recognize different epitopes on
the PNKP, were done to assess the possibility of the presence of residual PNKP or any
other isoforms of PNKP. Unfortunately, these blots have disclosed a band running close
to PNKP. The intensity of this band was almost 1/13th of of the band intensity at the same
concentration of the protein in WT (Fig. 8.12). Meanwhile, HeLa PNKP knockout cells
were obtained, and after confirming a clean knockout, DNA 3′ phosphatase and direct 5′kinase assays were repeated, reproducing very similar results as in HCT116 PNKP
knockout extracts. Although, ST042164, PNKP inhibitor obtained from Dr. Weinfeld’s
laboratory, inhibited the 100 ng pure PNKP’s 3′-phosphatase activity at 10 μM
concentration (Fig. 8.20), there was no effect was seen in the extracts even at 200 μM
concentration. However, when used in 1: 125 diluted extracts, marked inhibition was
visible in WT extracts but not in PNKP knockout extracts (Fig. 8.21). These findings gave
a positive indication of the presence and activity of other DNA 3′-phosphatases in the cell.
Since the 3′-phosphatase activity was observed at the DSB’s, we wanted to
evaluate if this function is a part of NHEJ. During NHEJ, autophosphorylation of the DNA
DSB bound DNA-PK complex is required for the accessibility of the ends to the end
processing proteins which take part in NHEJ. By blocking the autophosphorylation of
DNA-PK by the inhibitor, NU7441, this access can be limited. In both the extracts, the
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phosphatase activity observed appeared to be a function of NHEJ as revealed by the
DNA-PK inhibitor NU7441 treatment (Fig. 8.8). Moreover, availability of the DNA
substrate ends for 3′-phosphate end processing to a non-specific phosphatase (CIP) even
in the presence of NU7441 validates the above statement (Fig. 8.9). A cytoplasmic
protein phosphatase enzyme, DUSP 27, (Friedberg et al., 2007) was believed to
dephosphorylate DNA 3′ ends as it was identified to have a synthetic lethality with PNKP
loss. Also, Alkaline phosphatase is a membrane-bound and cytoplasmic enzyme that can
non-specifically dephosphorylate either 3′ or 5′ ends. However, the nuclear extracts
retained the 3′ phosphatase activity even in PNKP knockout extracts, suggesting a
nuclear presence of the unknown enzyme (Fig. 8.10 and 8.19).
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NU7441

Fig. 9.1: Role of DNA-PK in NHEJ and DNA DSB processing: Formation of DNA-PK
complex (Ku + DNA-PKcs) at the DSBs activates the kinase function on DNA-PKcs
resulting in a series of phosphorylation events which moves the complex away from the
ends and allowing for the accumulation of XLF-XRCC4-Ligase IV (ligation complex), at
the DSBs. Accessory repair factors accumulate on the scaffold of this ligation complex to
process the damaged ends and render them ligatable. By using a DNA-PK inhibitor,
NU7441, which blocks the kinase active site, all the phosphorylation events are blocked
thereby inhibiting the accumulation of either ligase complex or accessory factors. Thus,
PNKP or its alternative DNA 3′-phosphatase and 5′-kinase enzyme(s) (if it is a part of
NHEJ process), cannot function efficiently in the presence of NU7441. In our experiment
the DNA 3′-phosphatase and 5′-kinase enzyme(s) appeared to be a part of NHEJ as the
function was blocked in the presence of NU7441 (Fig. 8.10 and 8.19).
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The NHEJ mediated repair of the double strand break requires more than 15
factors including the core and accessory factors to form complexes and resolve the
complex strand breaks. Among the core proteins, XRCC4 is thought to be a central
scaffold that coordinates handoff of DNA repair intermediates between various DNA
repair enzymes (Aceytuno et al., 2017a). PNKP is shown to interact with both nonphosphorylated (XRCC4) and phosphorylated XRCC4 (pXRCC4), the latter being strong.
However, this interaction with pXRCC4 reduces the PNKP activity requiring DNA Ligase
IV in reversing the inhibitory effect of pXRCC4 on the turnover of the PNKP at the 5′phosphate ends. Structural studies have shown that XRCC4 forms a 1:2:1 PNKP:
pXRCC4: Ligase IV complex. XRCC4 and XLF homodimer proteins interact head to head
forming long helical protein filaments to facilitate DNA double-strand break repair.
(Mahaney, Hammel, Meek, Tainer, & Lees-Miller, 2013).
Further, the weak interaction between the PNKP catalytic domain and XRCC4–
Ligase IV, seem suitable to position PNKP to gain access to DNA within the XRCC4-XLF
filament (Aceytuno et al., 2017a). Based on these interacting studies, we wanted to
explore the role of XRCC4 and XLF in the activity of PNKP in XRCC4 knockout HCT116
and Bus cell (deficient in XLF) extracts, respectively. Many studies reported the influence
of XRCC4 on the kinase activity of the PNKP, with limited data on the phosphatase
function. When both the activities were assayed, as expected, there was reduction
observed for both the activities of PNKP in XRCC4 knockout extracts, only to be increased
after complementation of the protein with an exuberant end joining of both the substrates
(Fig. 8.11). Even though an increase, in the end joining of the partially complementary 3′137

phosphate substrates is conceivable, there was end joining of 5′-hydroxyl substrates with
no complementarity in the overhang. This end joining appeared as a diffuse band,
proposing a small resection at these ends (Fig. 8.11). This observation once again
illustrates the ability of XRCC4 to promote ligation at the incompatible ends (Pannunzio,
Watanabe, & Lieber, 2017). The inability of the added pure protein PNKP to restore the
kinase activity in the absence of XRCC4 might be due to the reduced turnover of the
PNKP after DNA 5′ phosphorylation (Mani et al., 2010b).This increased affinity of any
protein to its processed substrate is to protect the DNA ends until passed on to next
enzyme in the repair pathway (Hsiang et al., 1985). Further, there was no effect of XLF
deficiency on the phosphatase activity in the Bus cell extracts, but the kinase activity was
almost reduced to half, suggesting a role for XLF in influencing the processing of the 5′hydroxyl ends. As expected, presence end joining was evident only in the presence of
XLF, for the 3′-phosphate substrates which have a complementarity in the overhangs.
However, XLF was not able to join the non-complementary ends of the 5′-hydroxyl
substrates.
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Fig. 9.2: Role of XLF-XRCC4-Ligase IV complex in influencing PNKP activity: 1.
XLF-XRCC4-Ligase IV complex forms heterofilaments at the DSBs (for convenience
single complex is depicted). PNKP accumulates on the scaffold of XLF-XRCC4-Ligase IV
complex at the DSB for processing the DNA 5′-hydroxyl ends (also 3′-phosphate ends)
and phosphorylates 5′-OH ends. 2. XRCC4-Ligase IV complex is required for the turnover
of PNKP at the 5′-phosphorylated ends for reducing the affinity of PNKP to these
processed ends, so that it can act on other 5′-OH ends. Hence, an increase in kinase
activity (and phosphatase activity) was detected on adding back XRRC4/Ligase IV
complex to XRCC4 knockout extracts (Fig. 8.11). However, in our experiments XLF has
also enhanced the kinase activity (Fig 8.12), thus it is hypothesized that the XLF-XRCC4Ligase IV complex increases the turnover of PNKP and in the absence of this complex,
though PNKP can process the 5′-OH ends, remains bound to its substrates thereby
limiting its activity on other substrates. XLF-XRCC4-Ligase IV complex is depicted in the
box below.
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Ligation-mediated PCR experiments (LMPCR) done in the lab to visualize the
processing of DNA 3′-phosphate ends created by treatment of cells with the non-protein
chromophore of Neocarzinostatin (NCS-C),

have shown very rapid and similar 3′-

dephosphorylation in both wild-type and PNKP knockout HCT116 cells at 37 °C.
However, at 22 °C, there was a distinct delay in 3′-dephosphorylation of DSBs in PNKP
knockout cells, with 8-fold fewer 3′-hydroxyl DSB termini than in wild-type cells 5 min after
NCS-C addition and a 2 fold fewer at the 40 min time point at 22 °C. HeLa cells on the
other hand showed a reduction of processing of 3′-phosphate with 3-fold fewer 3′-hydroxyl
DSB termini at 5 and 15 min after treatment in PNKP knockout cells at 37 °C, although
by 40 min, processing was similar to wild-type. At 22 °C there were fewer 3′-hydroxyl
termini at least by 2-fold at all times with a 4-fold reduction at 40 min. These in-vivo 3′phosphatase assays, while they confirm a partial deficiency in 3′-dephosphorylation in
PNKP knockout cells, also suggest the presence of an alternative DNA 3′ phosphatase
enzyme(s) which can process the 3′-phosphate ends in the absence of PNKP, and show
that it is active in cells and not only extracts.
The disparity found in the DNA 3′-phosphatase activity detected in the
extracts and cells from the survival assays (decreased survival of the knockout cells
despite the repair seen in our 3′-phosphatase assays), can be explained by the creation
of other lesions such as SSB’s and 3′ phosphoglycolates by NCS, which in most cases
require PNKP, delaying or interfering with the complete DNA repair, surmounting to cell
death. Presence of the 53BP1 foci even after a long time suggests unrepaired DSB’s,
with some of the DSB’s going into a delayed repair in G1, (resection dependent NHEJ or
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Alt-NHEJ) which can lead to chromosomal translocations (Jeggo & Löbrich, 2017), or
repaired by HR in G2 (as the cells are non-synchronized).
Resistence to chemotherapy is seen as major problem in developing new
tartgets, especially the cell DNA damage response and repair factors. An enormous
amount of redundancy in these factors and the ability of the cancer cells to hijack various
pathways for the survival, poses a problem for a generalized targetting of the cancers.
Hence, before considering a factor as a desired target, it is imperative to rule out
redundancy. In the current scenario, PNKP appears to be a lucrative target due its crucial
role in various repair pathways. However, as with any other factor, PNKP function might
be duplicated by a redundant factor, whose function might not have been overtly obvious
in PNKP’s presence. Though lack of PNKP resulted in increased damage to cells, cancer
cells could utilise PNKP’s alternative for the survival. Hence, it would be wise to identify
these alternative 3′-phosphatase factors and develop pharmacogial agents to block their
activity in order to tackle future cancer therapy resistance.
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X Conclusion

Repair of complex lesions at the double strand breaks requires processing of the ends by
accessory factors. The nature of these lesions can be a deciding factor for the choice of
repair pathway/repair factor that will act upon these lesions. From the Thymine glycol (Tg)
study, we found that the Tg positioned at the fifth position is a better substrate than Tg at
third position for the BER repair protein, hNTH1, precluding the availability of these ends
for Non-homologous end joining. Similarly, from the PNKP experiment, we found that the
3′-phosphate at an overhang is better removed by the enzyme PNKP, than the one at the
recessed end. However, PNKP seemed to be the pivotal enzyme processing the
recessed 3′ ends.
Observations made in HCT116 and HeLa PNKP knockout extracts and cells suggest
the presence of an alternative enzyme(s) to PNKP, although, these enzymes play a
limited role in the absence of PNKP as seen by the survival assays. However, the
presence of minute amounts of PNKP must be ruled out by trying to immuno-deplete the
residual PNKP in the knockout extracts. Also, a recombinant ApeI which has a weak 3′
phosphatase activity, or Aprataxin can be tested either alone or in combination with other
NHEJ proteins such as XRCC4-Ligase IV to disclose their activity in the context of NHEJ,
in the absence of PNKP. Further, possibility that the increase lethality of the PNKP
knockout cells following treatment with NCS is due to increased DSB mis-joining resulting
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in lethal chromosome aberrations, can be investigated by FISH experiments to detect
chromosomal translocations. Also, by column separation of proteins in the PNKP
knockout extracts, different fractions can be tested for the presence of the DNA 3′phosphatase and 5′-kinase functions. After multiple column preparations (e.g. sizeexclusion, ion-exchange, and DNA affinity), the alternative DNA 3′-phosphatase(s) and
5′-kinase(s) might be isolated and identified by mass spectrometry.
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Appendix I

A.

B.

Figure 1: Restoration of DNA 3′-phosphatase activity by recombinant PNKP: To
determine the loss of 3′-phosphatase activity in knockout extracts is due to lack of PNKP,
recombinant protein (100 ng) was added to the Hct116 and HeLa PNKP knockout extracts
and incubated for different times. A) Plot derived from the observed percentage of
restoration of 3′-phosphatase activity on one base 3′-over hang substrate with time, in
HCT116 extracts. B) Gel image allowing the restoration of 3′-phosphatase activity by
PNKP addition on 3-base 3′-phosphate overhang substrate in HeLa knockout extracts.
The incubation time for all the reactions was 90 sec. As seen from the plot and gel, there
was restoration of the activity similar to activity seen in wild-type extracts.
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Appendix II

Human HCT116 PNK gene knock out Confirmation by DNA sequencing
Alignment of CRISPR clone 3-14 with PNK Exon 3 sequences (WT)
65 nucleotide were deleted and 10 nucleotide were rearranged in Allele 1; 78 nucleotide
were inserted and 2 separate nucleotides were mutated in Allele 2
E3-14-1

CTGGGAGTTAACCCCTCAACTACCGGGACCCAGGAGTTGAAGCCGGGGTTGGAGGGCTCT

E3-14-2

CTGGGAGTTAACCCCTCAACTACCGGGACCCAGGAGTTGAAGCCGGGGTTGGAGGGCTCT

PNK-Exon3

CTGGGAGTTAACCCCTCAACTACCGGGACCCAGGAGTTGAAGCCGGGGTTGGAGGGCTCT
************************************************************

E3-14-1

CTGGGGGTGGGGGACACACTGTATTTGGTCAATGG------------------------T

E3-14-2

CTGGGGGTGGGGGACACACTGTATTTGGTCAATGGCCTCCACCCACTGACCCTGCGCTGG

PNK-Exon3

CTGGGGGTGGGGGACACACTGTATTTGGTCAATGGCCTCCACCCACTGACCCTGCGCTGG
************************************************************

E3-14-1

GAAGATGCC---------------------------------------------------

E3-14-2

GAAGAGACCCGCACACCAGAATCCCAGCCAGATACTCCCGCACACCAGAATCCCAGAAGA

PNK-Exon3

GAAGAGACCCGCACACCAGAATCCCAGCCAGATACTCC---------------------**************************************

E3-14-1

------------------------------------------------------------

E3-14-2

GACCCGCACACCAGAATCCCAGCCAGATACTCCCGCACACCAGAATCCCAGAAGAGACCT

PNK-Exon3

--------------------------------------------------------GCCT
***
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E3-14-1

--------TCTGGTGTCCCAAGATGAGAAGAGAGATGCTGAGCTGCCGAAGAAGCATATG

E3-14-2

GGCACCCCTCTGGTGTCCCAAGATGAGAAGAGAGATGCTGAGCTGCCGAAGAAGCATATG

PNK-Exon3

GGCACCCCTCTGGTGTCCCAAGATGAGAAGAGAGATGCTGAGCTGCCGAAGAAGCATATG
************************************************************

E3-14-1

CGGAAGTCAAACCCCGGCTGGGAGAACTTGGAGAAGTTGCTAGTGTTCACCGCAGCTGGG

E3-14-2

CGGAAGTCAAACCCCGGCTGGGAGAACTTGGAGAAGTTGCTAGTGTCCACCGCAGCTGGG

PNK-Exon3

CGGAAGTCAAACCCCGGCTGGGAGAACTTGGAGAAGTTGCTAGTGTTCACCGCAGCTGGG
********************************************** *************

E3-14-1

GTGAAACCCCAGGGCAAG

E3-14-2

GTGAAACCCCAGGGCAAG

PNK-Exon3

GTGAAACCCCAGGGCAAG
******************
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Human HeLa PNK gene knock out Confirmation by DNA sequencing
There are three copies of PNK in HeLa cells. Genomic DNA sequences around short
guide RNA site of exon3 in clone 3-1-1 were sequenced.
DNA sequencing result showed that all three copies of PNK were modified.
Copy one
PNK3
PNK3-1-1c

CACTACCGGGACCCAGGAGTTGAAGCCGGGGTTGGAGGGCTCTCTGGGGGTGGGGGACAC
CACTACCGGGACCCAGGAGTTGAAGCCGGGGTTGGAGGGCTCTCTGGGGGTGGGGGACAC
************************************************************

PNK3
PNK3-1-1c

ACTGTATTTGGTCAATGGCCTCCACCCACTGACCCTGCGCTGGGAAGAGACCCGCACACC
ACTGTATTTGGTCAATGGCCTCCACCCACTGACCCTGCGCTGGGAAGAGACCCGCACACC
************************************************************

PNK3
PNK3-1-1c

AGAATCCCAGCCAGATACTCCGCCTGGCACCCCTCTGGTGTCCCAAGATGAGAAGAGAGA
AGAATCCCAGCCAGATACTCCGCCTGGCACCCCTCTGGTGTCCCAAGATGAGAAGAGAGA
************************************************************

PNK3
PNK3-1-1c

TGCTGAGCTGCCGAAG-AAGCGTATGCGGAAGTCAAACCCCGGCTGGGAGAACTTGGAGA
TGCTGAGCTGCCGAAGTAAGCGTATGCGGAAGTCAAACCCCGGCTGGGAGAACTTGGAGA
**************** *******************************************

PNK3
PNK3-1-1c

AGTTGCTAGTGTTCACCGCAGCTGGGGTGAAACCCCAGGGCAAGGTGAGGGCCACGCCGA
AGTTGCTAGTGTTCACCGCAGCTGGGGTGAAACCCCAGGGCAAGGTGAGGGCCACGCCGA
************************************************************

PNK3
PNK3-1-1c

GGGCTGAGGGAGCCGCCACAGACTGGGACCCAATCCCACGTTTGTTGCGTGCTCTCA
GGGCTGAGGGAGCCGCCACAGACTGGGACCCAATCCCACGTTTGTTGCGTGCTCTCA
*********************************************************
1 nucleotides were inserted into clone 3-1-1.

Copy two
PNK3
PNK3-1-1a

ACTACCGGGACCCAGGAGTTGAAGCCGGGGTTGGAGGGCTCTCTGGGGGTGGGGGACACA
ACTACCGGGACCCAGGAGTTGAAGCCGGGGTTGGAGGGCTCTCTGGGGGTGGGGGACACA
************************************************************

PNK3
PNK3-1-1a

CTGTATTTGGTCAATGGCCTCCACCCACTGACCCTGCGCTGGGAAGAGACCCGCACACCA
CTGTATTTGGTCAATGGCCTCCACCCACTGACCCTGCGCTGGGAAGAGACCCGCACACCA
************************************************************

PNK3
PNK3-1-1a

GAATCCCAGCCAGATACTCCGCCTGGCACCCCTCTGGTGTCCCAAGATGAGAAGAGAGAT
GAATCCCAGCCAGATACTCCGCCTGGCACCCCTCTGGTGTCCCAAGATGAGAAGAGAGAT
************************************************************
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PNK3
PNK3-1-1a

GCTGAGCTGCCGAAGA-------------------------------------------GCTGAGCTGCCGAAGACCTACAACCAGCTGTTCGAGGAAAACCCCATCAACGCCAGCGGC
****************

PNK3
PNK3-1-1a

-----------------------------------------------------------GTGGACGCCAAGGCCATCCTGTCTGCCAGACTGAGCAAGAGCAGACGGCTGGAAAATCTG

PNK3
PNK3-1-1a

-----------------------------------------------------------ATCGCCCAGCTGCCCGGCGAGAAGAAGAATGGCCTGTTCGGAAACCTGATTGCCCTGAGC

PNK3
PNK3-1-1a

-------AGCGTATGCGGAAGTCAAACCCCGGCTGGGAGAACTTGGAGAAGTTGCTAGTG
CTGGGCAAGCGTATGCGGAAGTCAAACCCCGGCTGGGAGAACTTGGAGAAGTTGCTAGTG
*****************************************************

PNK3
PNK3-1-1a

TTCACCGCAGCTGGGGTGAAACCCCAGGGCAAGGTGAGGGCCACGCCGAGGGCTGAGGGA
TTCACCGCAGCTGGGGTGAAACCCCAGGGCAAGGTGAGGGCCACGCCGAGGGCTGAGGGA
************************************************************

PNK3
PNK3-1-1a

GCCGCCACAGACTGGGACCCAATCCCACGTTTGTTGCGTGCTCTCA
GCCGCCACAGACTGGGACCCAATCCCACGTTTGTTGCGTGCTCTCA
**********************************************
171 nucleotides were inserted into clone 3-1-1.

Copy three
PNK-E3
PNK3-1-1jR

CTCCCTCTCTTTCTGCAGCTGGGAGTTAACCCCTCAACTACCGGGACCCAGGAGTTGAAG
CTCCCTCTCTTTCTGCAGCTGGGAGTTAACCCCTCAACTACCGGGACCCAGGAGTTGAAG
************************************************************

PNK-E3
PNK3-1-1jR

CCGGGGTTGGAGGGCTCTCTGGGGGTGGGGGACACACTGTATTTGGTCAATGGCCTCCAC
CCGGGGTTGGAGGGCTCTCTGGGGGTGGGGGACACACTGTATTTGGTCAATGGCCTCCAC
************************************************************

PNK-E3
PNK3-1-1jR

CCACTGACCCTGCGCTGGGAAGAGACCCGCACACCAGAATCCCAGCCAGATACTCCGCCT
CCACTGACCCTGCGCTGGGAAGAGACCCGCACACCAGAATCCCAGCCAGATACTCCGCCT
************************************************************

PNK-E3
PNK3-1-1jR

GGCACCCCTCTGGTGTCCCAAGATGAGAAGAGAGATGCTGAGCTGCCGAAG--------GGCACCCCTCTGGTGTCCCAAGATGAGAAGAGAGATGCTGAGCTGCCGAAGTAAGCGCGG
***************************************************

PNK-E3
PNK3-1-1jR

-----------------------------------------------------------CGGGTGTGGTGGTTACGCGCAGCGTGACCGCTACACTTGCCAGCGCCTTAGCGCCCGCTC

PNK-E3
PNK3-1-1jR

-----------------------------------------------------------CTTTCGCTTTCTTCCCTTCCTTTCTCGCCACGTTCGCCGGCTTTCCCCGTCAAGCTCTAA

PNK-E3
PNK3-1-1jR

-----------------------------------------------------------ATCGGGGGCTCCCTTTAGGGTTCCGATTTAGTGCTTTACGGCACCTCGACCCCAAAAAAC
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PNK-E3
PNK3-1-1jR

----------------AAGCGTATGCGGAAGTCAAACCCCGGCTGGGAGAACTTGGAGAA
TTGATTTGGGCGATGGAAGCGTATGCGGAAGTCAAACCCCGGCTGGGAGAACTTGGAGAA
********************************************

PNK-E3
PNK3-1-1jR

GTTGCTAGTGTTCACCGCAGCTGGGGTGAAACCCCAGGGCAAGGTGAGGGCCACGCCGAG
GTTGCTAGTGTTCACCGCAGCTGGGGTGAAACCCCAGGGCAAGGTGAGGGCCACGCCGAG
************************************************************

PNK-E3
PNK3-1-1jR

GGCTGAGGGAGCCGCCACAGACTGGGACCCAATCCCACGTTT
GGCTGAGGGAGCCGCCACAGAC-------------------**********************
205 nucleotides were inserted into clone 3-1-1.
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